Entries |
Document | Title | Date |
20080214983 | PRESSURE SENSING VALVE - A pressure sensing catheter having a pressure sensor and an antenna that is coupled to the pressure sensor, e.g., by a connector, are provided. The pressure sensor can be adapted to measure a pressure surrounding the catheter, and the antenna can be adapted to telemetrically communicate the measured pressure to an external device. In an exemplary embodiment, the antenna, pressure sensor, and/or connector are hermetically sealed, e.g., by the catheter and/or a coating, to prevent the antenna, pressure sensor, and connector from coming into contact with fluid, thereby allowing the catheter to be permanently implanted or otherwise used for long term use. Exemplary methods for manufacturing and using pressure sensing catheters are also provided. | 09-04-2008 |
20080221500 | Implant having MEMS Flow Module with Movable, Flow-Controlling Baffle - Various embodiments of MEMS flow modules that may be disposed in a flow path ( | 09-11-2008 |
20080221501 | Systems and Methods for Reducing Intraocular Pressure - The present invention provides systems and methods for reducing intraocular pressure, thereby to treat glaucoma and other disorders. The systems of the present invention include a shunt insertable across the clear cornea and a delivery device for inserting the shunt in the transcorneal position. The shunt has a body with a head at one end and a foot at the opposite end, and a channel therethrough permitting the passage of aqueous humor from the anterior chamber to the external surface of the cornea. A removable filter is positioned within the channel to regulate aqueous humor outflow and to resist the incursion of microorganisms. | 09-11-2008 |
20080228126 | Method of inhibiting disruption of the healing process in a physically modified stomach - Methods for inhibiting disruption of the healing process in a hollow body organ such as a stomach that is physically modified to restrict or reduce its food receiving capability are described. A physical boundary is used to form the stomach modification. An inlet portion of the modified stomach communicates with the esophagus and an outlet portion of the modified stomach communicates with the small intestine. A bypass shunt is inserted into the modified stomach alongside the physical boundary. The shunt enables food to pass from the esophagus through the shunt to the small intestine thereby reducing food and fluid contact with the physical boundary, and reducing pressure and tension forces at the physical boundary that establishes the stomach pouch. The shunt is inserted during the stomach modification procedure. | 09-18-2008 |
20080228127 | UVEOSCLERAL SHUNT AND METHODS FOR IMPLANTING SAME - Devices and methods for treating intraocular pressure are disclosed. The devices include shunts for draining aqueous humor from the anterior chamber to the uveoscleral outflow pathway, including the supraciliary space and the suprachoroidal space. The shunts are preferably implanted by ab interno procedures. | 09-18-2008 |
20080281250 | Self-Clearing Catheter for Clinical Implantation - The invention disclosed herein provides methods and apparati that utilize micro-electro-mechanical systems that can be used for example to prevent and/or clear obstructions in the fluid conduits of medical devices such as catheters. | 11-13-2008 |
20090005720 | Programmable Shunt with Electromechanical Valve Actuator - Devices and methods for regulating and directing bodily fluids from one region of a patient to another region are disclosed. In general, an apparatus is provided that can include an implantable shunt system and a system controller. The implantable shunt system can have an adjustable valve for regulating the flow of fluid, a sensor element for measuring a physiological characteristic of a patient, and an electromechanical valve actuator that can be adapted to adjust a resistance of the valve. The implantable shunt system can be in electrical communication with the system controller. The system controller can generally be adapted to receive a physiological characteristic of the patient and operate the electromechanical valve actuator to adjust a resistance of the valve. The apparatus can also include an external programming device that is in communication with the system controller. | 01-01-2009 |
20090024072 | METHODS AND SYSTEMS FOR ESTABLISHING RETROGRADE CAROTID ARTERIAL BLOOD FLOW - Interventional procedures on the carotid arteries are performed through a transcervical access while retrograde blood flow is established from the internal carotid artery to a venous or external location. A system for use in accessing and treating a carotid artery includes an arterial access device, a shunt fluidly connected to the arterial access device, and a flow control assembly coupled to the shunt and adapted to regulate blood flow through the shunt between at least a first blood flow state and at least a second blood flow state. The flow control assembly includes one or more components that interact with the blood flow through the shunt. | 01-22-2009 |
20090036820 | IMPLANTABLE FLOW CONNECTOR - An implantable flow connector for fluidically coupling a source tissue-enclosed body space with a destination element, comprising: a conduit having a lumen terminating at an orifice at a first end of the conduit implantable in the source body space through an opening formed in a tissue wall of the source body space, and a second end of the conduit implantable in the destination element through an opening in a surface of the destination element; and a circumferential flange, radially extending from the conduit proximate the conduit first end, configured to be implanted in the source body space adjacent an opening in the tissue wall of the source body space such that the conduit extends through the opening, the flange comprising one or more circumferentially adjacent sections at least one of which has a rigidity that decreases in a radially-increasing direction. | 02-05-2009 |
20090043243 | METHODS AND DEVICES FOR LOADING TEMPORARY HEMOSTATIC SEALS - Disclosed herein are methods, devices, and systems for folding a sealing element. A loader can receive a substantially unfolded sealing element, which when moved through the loader is configured for receipt in an insertion instrument. For example, the sealing element can be folded into a substantially prolate spheroidal shape. The folded sealing element can then be inserted into the insertion instrument. In one aspect, the loader is adapted to allow insertion of the folded sealing element into the insertion instrument when the folded sealing element is within a channel of the loader. | 02-12-2009 |
20090054827 | SYSTEM FOR USE IN DRAINING FLUID FROM A BRAIN OR SPINAL FLUID CAVITY UNTO ANOTHER BODY CAVITY OF A HUMAN BEING - This invention describes a method for processing pressure signals derivable from locations inside or outside a human or animal body or body cavity. Different aspects of the invention relate to a method for optimal differentiating between cardiac beat- and artifact-induced pressure waves and a method for obtaining new and improved information from said pressure signals. In particular, this invention describes a system for draining fluid from a brain or spinal fluid cavity according to the inventive method of processing pressure signals. | 02-26-2009 |
20090105631 | SYSTEMS AND METHODS FOR CONTROLLING RENOVASCULAR PERFUSION - Devices, systems and methods by which the real or apparent renovascular perfusion and intrarenal pressure may be selectively and controllably increased. By selectively and controllably increasing renovascular perfusion and interstitial hydrostatic pressure when the heart is unable to pump sufficient blood or when renal perfusion is suboptimal, the present invention reduces or reverses neurohormonal activation and fluid retention, and thereby minimizes their deleterious effects on the heart, vasculature, kidneys and other body systems. | 04-23-2009 |
20090112147 | Wireless Pressure Setting Indicator - Devices and methods useful for non-invasively indicating the position or setting of a mechanical device, such as a sensor or control in an implanted medical device, are disclosed. In one exemplary embodiment, a valve housing adapted to receive fluid flow therethrough is provided. The flow of fluid through the valve housing can be controlled, for example, by a valve assembly that has a plurality of predetermined pressure settings. A radio frequency tag can be disposed in the valve assembly, and the masking element and the radio frequency tag can be configured to move relative to one another. The relative positions of the masking element and the radio frequency tag can alter the response of the radio frequency tag to a wireless signal (which can be emitted from an external reading device, for example) and thereby indicate the pressure setting of the valve assembly. For example, in some embodiments, the masking element can selectively cover at least part of the radio frequency tag according to the pressure setting of the valve assembly, which can change a characteristic of the radio frequency tag's response to the wireless signal. | 04-30-2009 |
20090131849 | Heart regurgitation method and apparatus - A regurgitation implant may comprise a conduit or straw which may be coupled to a shaft. The shaft may be coupled to at least one anchor portion configured to couple the regurgitation implant to native coronary tissue. At least a portion of the conduit may be configured to be disposed proximate a mitral valve such that the regurgitation implant may interact and/or cooperate with at least a portion of the native mitral valve to induce a controlled amount of regurgitation through the conduit and therefore through the mitral valve. The regurgitation through the conduit and the mitral valve may cause the heart to dilute in a manner that is generally consistent with advanced disease of the heart. The amount of regurgitation may therefore be adjusted depending on the desired condition of the heart. | 05-21-2009 |
20090131850 | Method and apparatus for removing harmful proteins from a mammalian's ventricular cerebrospinal fluid - A method and apparatus for removing harmful organic anions and proteins from a mammalian's ventricular cerebrospinal fluid in the treatment of brain disorders. One embodiment comprises using an implanted pump and filter system in conjunction with a drug or enzyme to clean and filter a patient's cerebrospinal fluid. | 05-21-2009 |
20090131851 | FILTER ASSEMBLY WITH MICROFABRICATED FILTER ELEMENT - Various embodiments of MEMS flow modules that both filter and regulate pressure are disclosed. One such MEMS flow module ( | 05-21-2009 |
20090143713 | Biliary Shunts, Delivery Systems, Methods of Using the Same and Kits Therefor - The application discloses devices, systems, kits and methods for treating biliary disease. Device comprise, for example, a component configured for deployment between a gallbladder and location within a gastrointestinal tract of a patient which has a proximal end and a distal end with a lumen extending therethrough. A method of deploying the device can be achieved by, for example, creating a duct or fistula between a gallbladder lumen and a portion of a gastrointestinal tract; and providing for drainage from the gallbladder to the gastrointestinal tract. | 06-04-2009 |
20090156978 | Arterio-venous shunt devices - A long-term implantable arterio-venous shunt device is provided that can be used as a therapeutic method. The shunt device is implanted between an artery and a vein, preferably between the aorta and the inferior vena cava. The shunt device decreases the systemic vascular resistance and allows a blood flow rate through the shunt device of at least 5 ml/min after the implantation. The blood flow rate could be controlled either via an open loop or a closed loop control means. The shunt device could also be a self-adjustable shunt device to self-adjust its structure to control the blood flow rate through its lumen. Based on the effects of the shunt device to the respiratory, cardiac and circulatory system, the implantable shunt device could be beneficial as a therapy to patients with problems or conditions related to these systems. | 06-18-2009 |
20090204054 | TRANSCUTANEOUS TELEMETRY OF CEREBROSPINAL FLUID SHUNT PROGRAMMABLE-VALVE PRESSURE USING NEAR-INFRARED (NIR) LIGHT - An improvement for a programmable valve system of the type implanted in a patient and used to divert cerebrospinal fluid (CSF) from an intraventricular space to a terminus such as the peritoneal cavity. Such system includes means for establishing a flow path for the CSF to the terminus, which flow path includes a normally closed valve and means for adjusting the opening pressure of the valve in order to regulate the quantity of CSF diverted. The improvement enables an operator to be apprised of the actual opening pressure setting of the valve. A sensor is implantable at the patient and responds to the actual opening pressure setting, by generating an NIR telemetry signal indicative of the actual setting. This signal is transcutaneously transmitted through the skin of the patient to an external point. The telemetry signal is processed to produce observer intelligible data indicating the opening pressure setting of the valve. | 08-13-2009 |
20090275876 | DEVICE AND METHOD FOR ESTABLISHING AN ARTIFICIAL ARTERIO-VENOUS FISTULA - A shunt rivet for implantation in the aorta and inferior vena cava to treat chronic obstructive pulmonary disease, and a method of treating chronic obstructive pulmonary disease. | 11-05-2009 |
20090287136 | METHOD AND APPARATUS FOR FLUID DRAINAGE OF THE EYE - An implantable drain for the anterior chamber of the eye for venting fluid therefrom to relieve pressure. The device features a serpentine draining conduit having an aggregate length much longer than a liner conduit. The conduit is engaged within the sclera in a pocket formed under a scleral flap. The conduits may be interchanged with a shunt or other component communicating into the anterior chamber. | 11-19-2009 |
20090318844 | IMPLANTABLE FLUID MANAGEMENT DEVICE FOR THE REMOVAL OF EXCESS FLUID - A device for removing fluid from a first bodily cavity and for directing that fluid into a second bodily cavity while avoiding risks of infection and, in one embodiment, excessive dehydration of the first bodily cavity. The device includes an uptake tube having a proximal end in fluid communication with the first bodily cavity and a distal end in fluid communication with a pump, and an outflow tube having a proximal end in fluid communication with the pump and a distal end in fluid communication with the second bodily cavity. The distal end of the uptake tube may be coupled to a reservoir configured to expand upon ingression of fluid into the reservoir and to contract upon removal of fluid due to a negative pressure provided by the pump. | 12-24-2009 |
20090326432 | OCULAR IMPLANT - The present invention relates to an ocular implant, particularly a glaucoma stent. | 12-31-2009 |
20100010415 | HIGH PRESSURE RANGE HYDROCEPHALUS VALVE SYSTEM - A valve for use in a shunt system to drain fluid from one part of a patient's body to another is provided. In an exemplary embodiment, the valve is operable at a threshold pressure that is selectively adjustable up to at least about 400 mm H | 01-14-2010 |
20100010416 | GLAUCOMA TREATMENT DEVICE - Methods and devices are adapted for implanting into the eye. An incision is formed in the cornea of the eye and a shunt is inserted through the incision into the anterior chamber of the eye. The shunt includes a fluid passageway. The shunt is passed along a pathway from the anterior chamber through the scleral spur of the eye into the suprachoroidal space and positioned in a first position such that a first portion of the fluid passageway communicates with the anterior chamber and a second portion of the fluid passageway communicates with the suprachoroidal space to provide a fluid passageway between the suprachoroidal space and the anterior chamber. | 01-14-2010 |
20100022940 | Percutaneously Introduceable Shunt Devices and Methods - Catheters, implantable shunt devices and methods usable to establish passageways between blood vessels and/or other anatomical structures within the body of a human or animal subject. | 01-28-2010 |
20100056978 | Externally adjustable blood flow valve - A valve installed in a blood vessel can be externally adjusted over a wide range of flow rates. Such a valve can be incorporated in an AV shunt or AV fistula to allow large flow during dialysis and small flow at all other times. The valve can be activated by finger pressure, hypodermic needle or by an electromagnetic field. The valve is shaped like a Venturi tube with round cross section and smooth diameter transition to minimize blood damage and clotting. Hemodynamic properties are further enhanced by keeping the part coming in contact with the blood a single continuous tubing. | 03-04-2010 |
20100056979 | IMPLANTABLE OCULAR PUMP TO REDUCE INTRAOCULAR PRESSURE - A trabecular pump is implantable in the eye to reduce intraocular pressure. The pump drains aqueous humor from the anterior chamber into outflow pathways, such as Schlemm's canal. A feedback system includes an intraocular pump and a pressure sensor in communication with the pump, for regulating intraocular pressure. | 03-04-2010 |
20100076366 | MODULAR SPINAL FLUID FLOW REGULATION DEVICE AND METHOD - A shunt system for telemetrically measuring, regulating and/or adjusting cerebrospinal fluid flow rate, intercranial pressure, intraspinal pressure and/or intraventricular pressure and a method for use. The shunt system includes a shunt assembly, a first catheter and a second catheter that may be implanted using a novel introducer assembly. In addition to regulating fluid pressure and flow rate, the shunt system may also be used to deliver therapeutic compositions. | 03-25-2010 |
20100185138 | FLOW REGULATING IMPLANT, METHOD OF MANUFACTURE, AND DELIVERY DEVICE - An implant includes a tube for permitting fluid flow. A flow controlling rod may be inserted within the tube passage. One or more holes around the circumference of the tube may be selectively permanently or temporarily occluded to give desired flow characteristics. A delivery device for implanting the implant may include a central bore in which a retractable wire is located. The retractable wire penetrates a tube passage of the implant. After the implant is in position in the eye, the retention wire is retracted out of the implant. In a method for manufacturing an implant, two tubes of different diameters are utilized. The smaller tube fits inside the longitudinal bore of the larger tube. When the tubes are cut, the smaller tube forms the tube of the implant and the remaining portions of the larger tube form the retention projection and/or disk of the implant. | 07-22-2010 |
20100191168 | ENDOVASCULAR CEREBROSPINAL FLUID SHUNT - An implantable shunt device for draining cerebrospinal fluid from a patient's subarachnoid space. The device includes a shunt having opposed first and second ends. A one-way valve is located at the first end of the shunt. A helical tip is disposed at the second end. The helical tip is constructed to penetrate a sinus wall of the patient. Upon implantation, a hollow passageway extends between the helical tip and one-way valve such that fluid can be drained through the helical tip and out through the valve. The endovascular cerebrospinal fluid shunt of the present invention can be placed into a patient percutaneously via a catheter inserted into the venous system of the body through a needle hole, without the need for open surgery and the skin incisions required with current shunt devices. The device also allows for more physiologic drainage of cerebrospinal fluid since the device is shunting cerebrospinal fluid into the same cerebral venous system that occurs naturally in normal people. | 07-29-2010 |
20100191169 | METHOD AND APPARATUS FOR TREATING A CAROTID ARTERY - One disclosed embodiment comprises a method for treating lesions in the carotid artery of a mammalian body. The method comprises transcervical access and blocking of blood flow through the common carotid artery (with or without blocking of blood flow through the external carotid artery), shunting blood from the internal carotid artery and treating the lesion in the carotid artery. | 07-29-2010 |
20100191170 | METHOD AND APPARATUS FOR TREATING A CAROTID ARTERY - One disclosed embodiment comprises a method for treating lesions in the carotid artery of a mammalian body. The method comprises transcervical access and blocking of blood flow through the common carotid artery (with or without blocking of blood flow through the external carotid artery), shunting blood from the internal carotid artery and treating the lesion in the carotid artery. | 07-29-2010 |
20100210991 | METHODS AND CONDUITS FOR FLOWING BLOOD FROM A HEART CHAMBER TO A BLOOD VESSEL - Disclosed is a conduit that provides a bypass around an occlusion or stenosis in a coronary artery. The conduit is a tube adapted to be positioned in the heart wall to provide a passage for blood to flow between a heart chamber and a coronary artery, at a site distal to the occlusion or stenosis. The conduit has a section of blood vessel attached to its interior lumen which preferably includes at least one naturally occurring one-way valve positioned therein. The valve prevents the backflow of blood from the coronary artery into the heart chamber. | 08-19-2010 |
20100210992 | MULTI-BRANCHED ANTI-REFLUX VALVE - A shunt system includes a first catheter and a second catheter, each having a proximal end and a distal end, and at least one opening adjacent to its distal end. A proximal end of a drainage catheter is in fluid communication with the proximal end of the first catheter and the proximal end of the second catheter. A first one-way valve is disposed in fluid communication with the first catheter between its proximal end and its at least one opening. The first one-way valve effectively blocks fluid flow from the proximal end to the at least one opening. A second one-way valve is disposed in fluid communication with the second catheter between its proximal end and its at least one opening. The second one-way valve effectively blocks fluid flow from the proximal end to the at least one opening. | 08-19-2010 |
20100228179 | No clog shunt using a compact fluid drag path - The present invention is an improved shunt system for draining CSF. The system includes a removable sheath for reduction of catheter clogging during shunt insertion, a catheter with relatively large holes, an extracranial filter to allow non-invasive filter replacement, and a wireless flow/pressure meter to monitor and control CSF flow. | 09-09-2010 |
20100241049 | Systems, devices, and methods including infection-fighting and monitoring shunts - Systems, devices, methods, and compositions are described for providing an actively controllable shunt configured to, for example, monitor, treat, or prevent an infection. | 09-23-2010 |
20100241050 | Systems, devices, and methods including infection-fighting and monitoring shunts - Systems, devices, methods, and compositions are described for providing an actively controllable shunt configured to, for example, monitor, treat, or prevent an infection. | 09-23-2010 |
20100241051 | Systems, devices, and methods including infection-fighting and monitoring shunts - Systems, devices, methods, and compositions are described for providing an actively controllable shunt configured to, for example, monitor, treat, or prevent an infection. | 09-23-2010 |
20100241052 | Systems, devices, and methods including infection-fighting and monitoring shunts - Systems, devices, methods, and compositions are described for providing an actively controllable shunt configured to, for example, monitor, treat, or prevent an infection. | 09-23-2010 |
20100241053 | Systems, devices, and methods including infection-fighting and monitoring shunts - Systems, devices, methods, and compositions are described for providing an actively controllable shunt configured to, for example, monitor, treat, or prevent an infection. | 09-23-2010 |
20100241054 | Systems, devices, and methods including infection-fighting and monitoring shunts - Systems, devices, methods, and compositions are described for providing an actively controllable shunt configured to, for example, monitor, treat, or prevent an infection. | 09-23-2010 |
20100241055 | Systems, devices, and methods including infection-fighting and monitoring shunts - Systems, devices, methods, and compositions are described for providing an actively controllable shunt configured to, for example, monitor, treat, or prevent an infection. | 09-23-2010 |
20100249690 | Tools And Methods For Programming An Implantable Valve - A two-part tool for reading and adjusting an implantable valve, and methods of use. The tool includes a locator-indicator component that, when placed matingly on the patient's skin over the valve, provides magnetic reading of the valve setting. The tool also includes an adjustor component that couples to the locator-indicator component and is rotatable to change a valve setting. | 09-30-2010 |
20100249691 | GLAUCOMA SHUNTS WITH FLOW MANAGEMENT AND IMPROVED SURGICAL PERFORMANCE - A method of treating glaucoma in an eye by managing fluid flow past an implanted shunt having an elastomeric plate and a non-valved elastomeric drainage tube. The plate is positioned over a sclera of the eye with an outflow end of the elastomeric drainage tube open to an outer face of the plate. An inflow end of the drainage tube tunnels through the sclera to the anterior chamber of the eye. The plate may have regions of greater propensity for cell adhesion alternating with regions of lesser cell adhesion. For example, regions of texturing around the plate or drainage tube may be provided to control the size of a bleb that forms over the implant. The effective surface area of the plate may be balanced against a number of fenestrations. The drainage tube has a reduced profile and may be shaped with a non-circular external cross-section to reduce its height. A scleral groove may be used to further reduce the height of the drainage tube on the sclera. A flow restrictor for the early post operative period will immediately lower the intraocular pressure (IOP) and simultanously prevent hypotony. | 09-30-2010 |
20100249692 | Systems, devices, and methods including infection-Fighting and monitoring shunts - Systems, devices, methods, and compositions are described for providing an actively controllable shunt configured to, for example, monitor, treat, or prevent an infection. | 09-30-2010 |
20100262064 | Optimization of hydrocephalus shunt settings - A method is described for using a postoperative CSF dynamical examination to determine the CSF dynamical state of the patient and the dynamical state of the CSF shunt in conjunction therewith. | 10-14-2010 |
20100280431 | METHODS AND SYSTEMS FOR ESTABLISHING RETROGRADE CAROTID ARTERIAL BLOOD FLOW - Interventional procedures on the carotid arteries are performed through a transcervical access while retrograde blood flow is established from the internal carotid artery to a venous or external location. A system for use in accessing and treating a carotid artery includes an arterial access device, a shunt fluidly connected to the arterial access device, and a flow control assembly coupled to the shunt and adapted to regulate blood flow through the shunt between at least a first blood flow state and at least a second blood flow state. The flow control assembly includes one or more components that interact with the blood flow through the shunt. | 11-04-2010 |
20100298755 | DEVICES, SYSTEMS, AND METHODS TO TREAT HEART FAILURE HAVING AN IMPROVED FLOW-CONTROL MECHANISM - Several unique intra-cardiac pressure vents, placement catheters, methods of placement and methods of treating heart failure are presented. The intra-cardiac pressure vents presented remain partially open under normal intra-cardiac pressures to allow sufficient flow from the left atrium to the right atrium to enable the relief of elevated left atrial pressure and resulting patient symptoms, and also limit the amount of flow from the right atrium to the left atrium by closing when the pressure in the right atrium exceeds the pressure in the left atrium by a predetermined amount. | 11-25-2010 |
20100305492 | Cerebrospinal Fluid Purification System - The present invention provides methods and systems for conditioning cerebrospinal fluid (CSF). The methods provide for efficiently removing target compounds from CSF. The systems provide for a multilumen flow path and exchange of a majority volume portion of CSF in the CSF space. The removal and/or delivery of specific compounds can be tailored to the pathology of the specific disease. The removal is targeted and specific, for example, through the use of specific size-exclusion thresholds, antibodies against specific toxins, and other chromatographic techniques, as well as delivery and/or removal of targeted therapeutic agents. The invention finds use as a diagnostic, therapeutic and drug delivery platform for a variety of diseases affecting the CNS by accessing the CSF space. Exemplified disease conditions treatable by the present CSF processing systems and methods include, but are not limited to: Cerebral Vasospasm, Guillain Bane Syndrome, illustrating multi-lumen lumbar approach Alzheimer's, Parkinson's, Huntington's, Multiple Sclerosis, Amyotrophic Lateral Sclerosis, Spinal Cord Injury, Traumatic Brain Injury, Stroke, Cancer affecting the brain or spinal cord, Prion disease, Encephalitis from various causes, Meningitis from various causes, diseases secondary to enzymatic or metabolic imbalances, Biological Warfare, etc. For the first time, the present invention offers patients a disease-modifying, disruptive technology treatment platform that addresses the known disease pathogenesis of a number of neurologic conditions to which there are presently limited and ineffective treatment options. | 12-02-2010 |
20100305493 | Device for Controlling the Rate of Flow of a Fluid | 12-02-2010 |
20100312163 | IMPLANTABLE FLUID MOVEMENT DEVICE - An implantable fluid movement device is provided. The device is adapted to move body fluid from one part of the body of a patient to another part of the body and further adapted to secure the a tube end of the fluid movement device to a location inside a treated patient. | 12-09-2010 |
20100312164 | IMPLANTABLE DRAINAGE DEVICE - An implantable drainage device is provided. The device is adapted to move body fluid from one part of the body of a patient to another part of the body. | 12-09-2010 |
20100331757 | DIALYSIS VALVE AND METHOD - A dialysis valve includes a tube attached between an artery and a vein which, when elongated, simultaneously narrows in diameter at at least one location. The narrowed portion of the tube decreases the volume and velocity between the arterial and venous side of the patient to prevent damage or intimal hyperplasia on the venous side between dialysis treatments. When the valve is opened for dialysis, an unrestricted blood flow exists between the arterial and venous side, permitting a controlled, open blood flow during dialysis. | 12-30-2010 |
20110004147 | SYSTEM AND METHODS FOR CONTROLLING RETROGRADE CAROTID ARTERIAL BLOOD FLOW - A retrograde flow system is configured for treating an artery. The system includes an arterial access device adapted to be introduced into an artery and receive blood flow from the artery. A shunt fluidly is connected to the arterial access device, wherein the shunt provides a pathway for blood to flow from the arterial access device to a return site. A flow control assembly is coupled to the shunt and is adapted to regulate blood flow through the shunt between at least a first blood flow state and at least a second blood flow state. A shut-off valve assembly automatically blocks fluid flow through the shunt in response to injection of the fluid into the arterial access device. | 01-06-2011 |
20110040233 | WIRELESS PRESSURE SETTING INDICATOR - Devices and methods useful for non-invasively indicating the position or setting of a mechanical device, such as a sensor or control in an implanted medical device, are disclosed. In one exemplary embodiment, a valve housing adapted to receive fluid flow therethrough is provided. The flow of fluid through the valve housing can be controlled, for example, by a valve assembly that has a plurality of predetermined pressure settings. A radio frequency tag can be disposed in the valve assembly, and the masking element and the radio frequency tag can be configured to move relative to one another. The relative positions of the masking element and the radio frequency tag can alter the response of the radio frequency tag to a wireless signal (which can be emitted from an external reading device, for example) and thereby indicate the pressure setting of the valve assembly. For example, in some embodiments, the masking element can selectively cover at least part of the radio frequency tag according to the pressure setting of the valve assembly, which can change a characteristic of the radio frequency tag's response to the wireless signal. | 02-17-2011 |
20110054382 | CEREBROSPINAL FLUID EVALUATION SYSTEM HAVING THERMAL FLOW AND FLOW RATE MEASUREMENT PAD USING A PLURALITY OF CONTROL SENSORS - A method and device for testing for the presence, absence and/or rate of flow in a shunt tubing implanted under the skin by using a measurement pad having a plurality of temperature sensors, one of which is aligned with the shunt and the other sensors being symmetrically displaced on either side of the first temperature sensor in a direction transverse to the shunt tubing. These “outer” temperature sensors act as control temperature sensors. A temperature source, e.g., a cooling agent, positioned within an insulated enclosure, is then applied at a predetermined location on the measurement pad that is insulated from the temperature sensors. The movement of this temperature “pulse” is detected by the shunt-aligned temperature sensor via the shunt tubing as the CSF carries the temperature pulse while the control sensors detect the pulse via convection through the skin. The temperature data from these sensors are provided to a CSF analyzer that determines a CSF shunt flow status or flow rate. | 03-03-2011 |
20110060265 | IMPLANTABLE SHUNT OR CATHETER ENABLING GRADUAL DELIVERY OF THERAPEUTIC AGENTS - An implantable catheter or shunt for draining fluid from a body cavity. The catheter or shunt body has a wall structure that carries one or more therapeutic agents in a manner enabling release of the therapeutic agent from the wall structure in situ after surgical implantation of the catheter or shunt body. The therapeutic agent can be gradually released over time to prevent infection, inhibit tissue ingrowths, and/or provide some other desired medicinal purpose. As an example, the therapeutic agent can be rapamycin or an mTOR inhibitor. According to some contemplated embodiments of the present invention, the therapeutic agent carried by the catheter/shunt is rechargeable or refillable in situ so that the therapeutic agent can be gradually released from the catheter/shunt over the expected useful life of the catheter/shunt. | 03-10-2011 |
20110066098 | NON-INVASIVELY ADJUSTABLE DRAINAGE DEVICE - The device comprises at least an inlet tube for the passage of fluid to be drained, said tube being connected to a chamber wherein said chamber comprises rotating means for adjusting the flow rate in said tube. | 03-17-2011 |
20110071456 | Lumen Clearing Valve For Glaucoma Drainage Device - A glaucoma drainage device has a housing with an open outlet end. A tube is in fluid communication with the housing. An actuator is located in the housing. An actuation arm is located at least partially in the housing and is coupled to the actuator. A tapered arm is rigidly coupled to the actuation arm. A needle head is located opposite the tapered arm. A tapered end of the tapered arm is located at least partially in the tube. When the tapered arm is moved, it can clear an obstruction from the tube. When the needle head is moved, it can disperse aqueous or clear fibers from the drainage location. | 03-24-2011 |
20110071457 | Method and apparatus for controlling intracranial pressure - A regulator system and method are provided for controlling intracranial pressure (ICP) of a patient in a manner that permits continuous control of ICP to keep it on any clinically desired path over time. A nonlinear feedback control scheme for a CSF drainage valve embodies a relationship between intracranial pressure and infusion rate of CSF and an ICP state linearizer to keep the ICP on the clinically desired path over time. | 03-24-2011 |
20110071458 | Glaucoma Drainage Device with Pump - A glaucoma drainage device may comprise a main drainage tube with a first end configured to be located in an anterior chamber of an eye and a second end configured to be located in a drainage location. A bypass drainage tube is fluidly coupled to and in parallel with the main drainage tube. A pump is in communication with the bypass drainage tube. The pump comprises a first driver and a first flexible membrane enclosing a first chamber. A first check valve is located upstream of the pump, and a second check valve is located downstream of the pump. An active valve is located upstream of the first check valve. The active valve comprises a second driver and a second flexible membrane enclosing a second chamber. A third check valve is located between the active valve and the second end of the main drainage tube. A volume of the first chamber is changed to pump fluid from the anterior chamber to the drainage location. | 03-24-2011 |
20110071459 | Power Saving Glaucoma Drainage Device - A glaucoma drainage device has an active valve configured to be located between an anterior chamber of an eye and a drainage location, a power source coupled to the active valve, and a controller coupled to the power source. A first pressure sensor is located in fluid communication with the anterior chamber, a second pressure sensor is located in the drainage location, and a third pressure sensor located remotely from the first and second pressure sensors. The controller reads the first, second, and third pressure sensors once during a period of time and adjusts the active valve to control intraocular pressure. | 03-24-2011 |
20110082408 | METHOD AND APPARATUS FOR TREATING A CAROTID ARTERY - One disclosed embodiment comprises a method for treating lesions in the carotid artery of a mammalian body. The method comprises transcervical access and blocking of blood flow through the common carotid artery (with or without blocking of blood flow through the external carotid artery), shunting blood from the internal carotid artery and treating the lesion in the carotid artery. | 04-07-2011 |
20110092879 | BARIATRIC DEVICE AND METHOD - A bariatric device and method of causing at least partial satiety includes a body that is adapted to be positioned at i) an abdominal portion of the esophagus and/or ii) a proximal cardiac portion of the stomach. The body has a wall defining a lumen. The wall is configured to generally conform to the shape and size of i) the abdominal portion of the esophagus and/or ii) the proximal cardiac portion of the stomach. A force is exerted with the wall at i) the abdominal portion of the esophagus and/or (ii) the proximal cardiac portion of the stomach thereby influencing a neurohormonal feedback mechanism of the patient to cause at least partial satiety by augmenting fullness caused by food and simulating fullness in the absence of food. The method further includes adjusting the force exerted with the wall. | 04-21-2011 |
20110098630 | Methods And Devices For Anchoring A Gastroenterologic Sleeve - A gastroenterologic sleeve is anchored within the digestive tract, without tissue-puncturing mechanisms, by providing anchoring mechanisms that utilize the inherent shape of the stomach to prevent sleeve migration. In at least two embodiments, the anchoring mechanism expands to conform to the interior stomach walls. In other embodiments, internal pessary rings are held in place at the gastroesophageal junction by an external band. A delivery device is provided for implanting the various device transesophageally. | 04-28-2011 |
20110105991 | Tools and methods for programming an implantable valve - Integrated tools for noninvasively reading and adjusting an implantable, magnetically adjustable valve, and methods of use are disclosed. The tools include magnetic or electronic reading of the valve, and magnetic or electromagnetic adjustment of the valve. In use, the tools are positioned above or in contact with the patient's skin, in proximity to the valve. | 05-05-2011 |
20110105992 | Tools and methods for programming an implantable valve - Integrated tools for noninvasively reading and adjusting an implantable, magnetically adjustable valve, and methods of use are disclosed. The tools include magnetic or electronic reading of the valve, and magnetic or electromagnetic adjustment of the valve. In use, the tools are positioned above or in contact with the patient's skin, in proximity to the valve. | 05-05-2011 |
20110105993 | Tools and Methods for Programming an Implantable Valve - Integrated tools for noninvasively reading and adjusting an implantable, magnetically adjustable valve, and methods of use are disclosed. The tools include magnetic or electronic reading of the valve, and magnetic or electromagnetic adjustment of the valve. In use, the tools are positioned above or in contact with the patient's skin, in proximity to the valve. | 05-05-2011 |
20110105994 | Tools and Methods for Programming an Implantable Valve - Integrated tools for noninvasively reading and adjusting an implantable, magnetically adjustable valve, and methods of use are disclosed. The tools include magnetic or electronic reading of the valve, and magnetic or electromagnetic adjustment of the valve. In use, the tools are positioned above or in contact with the patient's skin, in proximity to the valve. | 05-05-2011 |
20110112460 | ADJUSTABLE VALVE SETTING WITH MOTOR CONTROL - An implantable medical device is disclosed that includes a valve body and a valve rotor adjustable with respect to the valve body. A tool can be utilized to determine and control a position of the valve rotor with respect to the valve body. The tool can include a valve body position reader, a valve rotor position reader and a valve rotor position controller to determine a valve setting for the device and adjust the valve setting as desired. | 05-12-2011 |
20110118650 | METHOD AND APPARATUS FOR TREATING OBESITY AND CONTROLLING WEIGHT GAIN AND ABSORPTION OF GLUCOSE IN MAMMALS - The present invention includes an endoluminal sleeve having a stomach sleeve portion, an antral sleeve portion, and an intestine sleeve portion. The endoluminal sleeve includes a flexible core layer which is formed from a self-expanding material. The flexible core layer in the stomach sleeve portion can self expand to grip the stomach. The antral sleeve is located in the pyloric antrum and is connected to the stomach sleeve portion and the intestine sleeve portion. The intestine sleeve portion is connected to the antral sleeve through a junction. The junction contains non-self-expanding material allowing the pyloric sphincter to properly function. The intestine sleeve portion is located in the small intestines. The intestine sleeve portion can have fenestrations, roots, a nutrient delivery layer, a nutrient delivery cover, an outer shell with a plurality of holes, and/or a semi-porous skin for nutrient delivery to the small intestines. | 05-19-2011 |
20110118651 | METHOD AND APPARATUS FOR EFFECTING A PERCUTANEOUS AORTIC VALVE BYPASS - A method for performing a percutaneous valve bypass, the method comprising:
| 05-19-2011 |
20110130700 | Bypass device for influencing blood pressure - A bypass device for influencing blood pressure, including an implant with a volumetric chamber, having a connector or connecting means for connecting the volumetric chamber to a natural cardiovascular system, and having an adaptor or adaptation means, by which a change in volume of a volume of the volumetric chamber is enabled or effected upon a pressure change in the cardiovascular system or in the volumetric chamber. According to this invention, a change in volume in a lower pressure range between 50 mmHg and a pressure threshold value amounting to at least 100 mmHg amounts to at most 10 cm | 06-02-2011 |
20110130701 | FLOW CONTROL METHOD AND DEVICE - An arterio-venous graft ( | 06-02-2011 |
20110130702 | FLOW CONTROL METHOD AND DEVICE - An arterio-venous graft ( | 06-02-2011 |
20110160638 | Electrokinetic actuator to titrate fluid flow - An electrokinetic actuator for fluid flow titration including two chambers separated from one another by a porous dielectric disposed therebetween. A plurality of electrodes are disposed about a perimeter of the first and second chambers. Polar electrolyte disposed within the actuator is able to pass through the porous dielectric between the first and second chambers upon the application of an electric field or electric potential to the plural electrodes. A mechanical valve actuation mechanism connected to the second chamber allows for fine titration of fluid flow using electro-osmosis, including full-flow and/or complete cut-off. The polar electrolyte is isolated to prohibit intermixing with a fluid being titrated (such as cerebrospinal fluid). | 06-30-2011 |
20110166495 | CEREBROSPINAL FLUID DRAINAGE - A cerebrospinal fluid drainage. The abstract of the disclosure is submitted herewith as required by 37 C.F.R. §1.72(b). As stated in 37 C.F.R. §1.72(b): A brief abstract of the technical disclosure in the specification must commence on a separate sheet, preferably following the claims, under the heading “Abstract of the Disclosure.” The purpose of the abstract is to enable the Patent and Trademark Office and the public generally to determine quickly from a cursory inspection the nature and gist of the technical disclosure. The abstract shall not be used for interpreting the scope of the claims. Therefore, any statements made relating to the abstract are not intended to limit the claims in any manner and should not be interpreted as limiting the claims in any manner. | 07-07-2011 |
20110166496 | METHODS AND SYSTEMS FOR ESTABLISHING RETROGRADE CAROTID ARTERIAL BLOOD FLOW - Interventional procedures on the carotid arteries are performed through a transcervical access while retrograde blood flow is established from the internal carotid artery to a venous or external location. A system for use in accessing and treating a carotid artery includes an arterial access device, a shunt fluidly connected to the arterial access device, and a flow control assembly coupled to the shunt and adapted to regulate blood flow through the shunt between at least a first blood flow state and at least a second blood flow state. The flow control assembly includes one or more components that interact with the blood flow through the shunt. | 07-07-2011 |
20110166497 | METHODS AND SYSTEMS FOR ESTABLISHING RETROGRADE CAROTID ARTERIAL BLOOD FLOW - Interventional procedures on the carotid arteries are performed through a transcervical access while retrograde blood flow is established from the internal carotid artery to a venous or external location. A system for use in accessing and treating a carotid artery includes an arterial access device, a shunt fluidly connected to the arterial access device, and a flow control assembly coupled to the shunt and adapted to regulate blood flow through the shunt between at least a first blood flow state and at least a second blood flow state. The flow control assembly includes one or more components that interact with the blood flow through the shunt. | 07-07-2011 |
20110178454 | Methods And Devices For Performing Gastroplasty - A gastroplasty method involves a staple line that terminates prior to reaching the gastroesophageal junction such that the bypassed portion of the stomach does not require resection. Additionally, bougies are taught that assist a physician in following the improved staple line of the present invention. | 07-21-2011 |
20110178455 | IMPLANTABLE FLUID MANAGEMENT SYSTEM FOR THE REMOVAL OF EXCESS FLUID - An implantable fluid management device, designed to drain excess fluid from a variety of locations in a living host into a second location within the host, such as the bladder of that host. The device may be used to treat ascites, chronic pericardial effusions, normopressure hydrocephalus, hydrocephalus, pulmonary edema, or any fluid collection within the body of a human, or a non-human mammal. | 07-21-2011 |
20110190684 | METHOD AND APPARATUS FOR REDUCING OBESITY - Method and apparatus for treatment of morbid obesity by placement of a series of flow reduction elements in the small intestine to induce satiety are disclosed. The flow reduction elements restrict the movement of partially digested food and reduce the flow rate through the small intestine which causes the emptying of the stomach and the duodenum to occur slower. The flow reduction elements are attached to an elongated tube and are constructed from various shapes and configurations. The flow reduction elements may be inflated with fluid or may be constructed from self-expandable materials. The device is anchored in the antrum of the stomach with an anchoring member. The transoral gastric device can be inserted with a delivery catheter through the working lumen of an endoscope or alongside an endoscope and may be removed with the aid of an endoscope if desired. | 08-04-2011 |
20110196281 | SHUNT DEVICE AND METHOD FOR TREATING OCULAR DISORDERS - Shunt devices and a method for continuously decompressing elevated intraocular pressure in eyes affected by glaucoma by diverting excess aqueous humor from the anterior chamber of the eye into Schlemm's canal where post-operative patency can be maintained with an indwelling shunt device which surgically connects the canal with the anterior chamber. The shunt devices provide uni- or bi-directional flow of aqueous humor into Schlemm's canal. | 08-11-2011 |
20110196282 | DEVICES, SYSTEMS, AND METHODS FOR AUTORETROPERFUSION - Devices, systems, and methods for autoretroperfusion. In at least one embodiment of a perfusion system of the present disclosure, the system comprises a first catheter having a proximal end, a distal end, and a first lumen therethrough, the distal end configured for insertion into a luminal organ of a patient, a coupler defining an outlet port and a first port, the coupler configured to engage the proximal end of the first catheter at the outlet port and to receive blood from a blood supply through the first port, a first tube having a proximal end, a distal end, and a lumen therethrough, the distal end of the first tube configured to engage the first port of the coupler and to receive the blood from the blood supply, and a first flow regulator in communication with one or more of the coupler and the first tube, the first flow regulator operable to regulate a flow and/or a pressure of the blood through at least part of the system, wherein the system is configured to permit the blood from the blood supply to flow through the first tube, the coupler, and the first catheter into the patient to treat a patient condition. | 08-11-2011 |
20110201990 | SYSTEM AND METHOD TO INCREASE THE OVERALL DIAMETER OF VEINS - A system and method for increasing the speed of blood and wall shear stress (WSS) in a peripheral vein for a sufficient period of time to result in a persistent increase in the overall diameter and lumen diameter of the vein is provided. The method includes pumping blood at a desired rate and pulsatility. The pumping is monitored and adjusted, as necessary, to maintain the desired blood speed, WSS and pulsatility in the peripheral vein in order to optimize the rate and extent of dilation of the peripheral vein. | 08-18-2011 |
20110201991 | VALVE BYPASS GRAFT DEVICE, TOOLS, AND METHOD - A medical implant comprises a hollow conduit having a first end opening, a second end opening, and a slit opening located between said first and second end openings, and a one way valve located within said conduit. | 08-18-2011 |
20110218477 | Methods and apparatus for reducing localized circulatory system pressure - The present invention is thus directed to methods and apparatus for decreasing pressure in a first portion of a vessel of the cardiac structure of a patient by implanting a shunt communicating with an area outside said first portion, whereby a volume of blood sufficient to reduce pressure in said first portion is released. Preferably, the first portion comprises the left ventricle and the pressure reduced is the end diastolic pressure, which is accomplished by having the shunt communicate with the left ventricle so a small volume of blood is released from the left ventricle to reduce the end diastolic pressure. Most preferably, the shunt selectively permits flow when a pressure differential between the left ventricle and another chamber of a heart above a threshold pressure, whereby shunting is prevented during left ventricular systole, or, alternatively, selectively permits flow when a pressure differential between the left ventricle and another chamber of a heart is between a lower threshold and a higher threshold, whereby shunting is again prevented during left ventricular systole. In certain embodiments a semi-passive check-valve is controlled and actuated by an external signal, either using a signal generated by an intra-corporeal electrical battery or an externally coupled energy source. In certain embodiments, the shunt has a pump with an input connected to the left ventricle, or other portion with excessive pressure, and an output connected to a volume of lower pressure. The preferred method of implanting the shunt to effect the present invention is by deploying a tubular element having two ends and a tissue affixation element disposed at each of said ends via a catheter, preferably, the fixation element is a shape retaining metallic material that returns to its original shape as part of the retention aspect of its function. In preferred embodiments of the apparatus, the tubular element is comprised of a biologically inert non-metallic material. | 09-08-2011 |
20110218478 | METHODS AND APPARATUS FOR REDUCING LOCALIZED CIRCULATORY SYSTEM PRESSURE - The present invention is thus directed to methods and apparatus for decreasing pressure in a first portion of a vessel of the cardiac structure of a patient by implanting a shunt communicating with an area outside said first portion, whereby a volume of blood sufficient to reduce pressure in said first portion is released. Preferably, the first portion comprises the left ventricle and the pressure reduced is the end diastolic pressure, which is accomplished by having the shunt communicate with the left ventricle so a small volume of blood is released from the left ventricle to reduce the end diastolic pressure. Most preferably, the shunt selectively permits flow when a pressure differential between the left ventricle and another chamber of a heart above a threshold pressure, whereby shunting is prevented during left ventricular systole, or, alternatively, selectively permits flow when a pressure differential between the left ventricle and another chamber of a heart is between a lower threshold and a higher threshold, whereby shunting is again prevented during left ventricular systole. In certain embodiments a semi-passive check-valve is controlled and actuated by an external signal, either using a signal generated by an intra-corporeal electrical battery or an externally coupled energy source. In certain embodiments, the shunt has a pump with an input connected to the left ventricle, or other portion with excessive pressure, and an output connected to a volume of lower pressure. The preferred method of implanting the shunt to effect the present invention is by deploying a tubular element having two ends and a tissue affixation element disposed at each of said ends via a catheter, preferably, the fixation element is a shape retaining metallic material that returns to its original shape as part of the retention aspect of its function. In preferred embodiments of the apparatus, the tubular element is comprised of a biologically inert non-metallic material. | 09-08-2011 |
20110218479 | DEVICE AND METHOD FOR CONTROLLING IN-VIVO PRESSURE - A differential pressure regulating device is provided for controlling in-vivo pressure in a body, and in particularly in a heart. The device may include a shunt being positioned between two or more lumens in a body, to enable fluids to flow between the lumens, and an adjustable flow regulation mechanism being configured to selectively cover an opening of the shunt, to regulate the flow of fluid through the shunt in relation to a pressure difference between the body lumens. In some embodiments a control mechanism coupled to the adjustable flow regulation mechanism may be provided, to remotely activate the adjustable flow regulation mechanism. | 09-08-2011 |
20110218480 | DEVICE AND METHOD FOR CONTROLLING IN-VIVO PRESSURE - A differential pressure regulating device is provided for controlling in-vivo pressure in a body, and in particularly in a heart. The device may include a shunt being positioned between two or more lumens in a body, to enable fluids to flow between the lumens, and an adjustable flow regulation mechanism being configured to selectively cover an opening of the shunt, to regulate the flow of fluid through the shunt in relation to a pressure difference between the body lumens. In some embodiments a control mechanism coupled to the adjustable flow regulation mechanism may be provided, to remotely activate the adjustable flow regulation mechanism. | 09-08-2011 |
20110218481 | DEVICE AND METHOD FOR CONTROLLING IN-VIVO PRESSURE - A differential pressure regulating device is provided for controlling in-vivo pressure in a body, and in particularly in a heart. The device may include a shunt being positioned between two or more lumens in a body, to enable fluids to flow between the lumens, and an adjustable flow regulation mechanism being configured to selectively cover an opening of the shunt, to regulate the flow of fluid through the shunt in relation to a pressure difference between the body lumens. In some embodiments a control mechanism coupled to the adjustable flow regulation mechanism may be provided, to remotely activate the adjustable flow regulation mechanism. | 09-08-2011 |
20110230815 | SYRINX CAVITY SHUNT DEVICE AND METHOD - A shunt is provided having a first catheter end with one or more apertures that provide access to an interior of the shunt. At least a portion of the first catheter end has a substantially helical shape and the one or more apertures are disposed on an interior surface of the substantially helical shape of the first catheter end. The shunt also includes a second catheter end providing access to the interior of the shunt for drainage of the shunt at a remote location. The shunt further includes a catheter body disposed between the first catheter end and the second catheter end. | 09-22-2011 |
20110245753 | APPARATUS AND METHOD FOR LOWERING INTRAOCULAR PRESSURE IN AN EYE - An eye mounted device configured to actively evacuate fluid from the anterior chamber of the eye to an exterior region or the sclera of the eye. The device employs a miniature pump powered by a photovoltaic cell which is mounted in the clear corneal tissue and which may be curved in the same shape as the eye. One or a combination of pressure sensors and timers determine the duration the device evacuates fluid from the user's eye. | 10-06-2011 |
20110275976 | METHOD OF REGULATING CSF DRAINAGE - An implantable drainage device for draining the cerebro-spinal fluid of a patient, the device including:
| 11-10-2011 |
20110282264 | METHOD OF DRAINING CEREBROSPINAL FLUID - A method of draining cerebrospinal fluid from a human brain. The method includes providing a drainage catheter having a proximal end and a distal end. The drainage catheter has a plurality of openings formed therein. The plurality of openings includes a first opening, a second opening, and a most proximal opening. The second opening is disposed closer to the distal end than the first opening. A cross-sectional area of the first opening is less than a cross-sectional area of the second opening. The distal end of the drainage catheter is inserted into a human brain. Cerebrospinal fluid is drained from the human brain. The cerebrospinal fluid passes into the drainage catheter through the plurality of openings and out of the drainage catheter through the proximal end. A rate at which the cerebrospinal fluid passes through the drainage catheter is controlled to maintain intracranial pressure within a selected range. | 11-17-2011 |
20110295182 | METHODS FOR LOADING A PROSTHESIS - The present disclosure relates to devices and methods for implanting a prosthesis into a heart of a mammal, such as a person. The disclosure includes a prosthesis that acts as a pressure vent between the left and right atria of the heart. The disclosure also includes a mounting tool for mounting the prosthesis onto a loading tool, the loading tool useful for loading the prosthesis onto a device for delivering the prosthesis into the patient's heart. Control devices and methods for using these devices are also disclosed. The intracardiac pressure vents disclosed allow sufficient flow from the left atrium to the right atrium to relieve elevated left atrial pressure and resulting patient symptoms. The devices also limit the amount of flow from the right atrium to the left atrium to minimize the potential for thrombi or other embolic material from entering arterial circulation. | 12-01-2011 |
20110295183 | CONTROL DEVICES FOR DEPLOYING A PROSTHESIS - The present disclosure relates to devices and methods for implanting a prosthesis into a heart of a mammal, such as a person. The disclosure includes a prosthesis that acts as a pressure vent between the left and right atria of the heart. The disclosure also includes a mounting tool for mounting the prosthesis onto a loading tool, the loading tool useful for loading the prosthesis onto a device for delivering the prosthesis into the patient's heart. Control devices and methods for using these devices are also disclosed. The intracardiac pressure vents disclosed allow sufficient flow from the left atrium to the right atrium to relieve elevated left atrial pressure and resulting patient symptoms. The devices also limit the amount of flow from the right atrium to the left atrium to minimize the potential for thrombi or other embolic material from entering arterial circulation. | 12-01-2011 |
20110306916 | DEVICE AND METHOD FOR REGULATING PRESSURE IN A HEART CHAMBER - A device for regulating blood pressure in a heart chamber is provided. The device includes a shunt positionable within a septum of the heart. The shunt is designed for enabling blood flow between a left heart chamber and a right heart chamber, wherein the flow rate capacity of the device is mostly a function of pressure in the left heart chamber. | 12-15-2011 |
20110313341 | DEVICES, SYSTEMS, AND METHODS FOR ORGAN RETROPERFUSION - Devices, systems, and methods for organ retroperfusion. In at least one embodiment of a method of organ perfusion of the present disclosure, the method comprises the steps of positioning at least part of a first catheter having a cannula within an artery of a patient, the first catheter configured to permit arterial blood to flow therethrough and further configured to permit a portion of the arterial blood to flow through the cannula, positioning at least part of a second catheter within a vein of the patient at or near a target organ, the second catheter configured to receive some or all of the portion of the arterial blood, and connecting the cannula of the first catheter to a portion of the second catheter so that some or all of the portion of the arterial blood flowing through the cannula is provided into the vein to treat a condition or disease of the target organ. | 12-22-2011 |
20120004590 | SATIATION POUCHES AND METHODS OF USE - A method for controlling appetite by means of a satiation device is disclosed. The device, which includes a flexible webbing defining proximal and distal openings and a biasing structure, is attached to the patient's stomach with the proximal opening positioned adjacent and below the patient's gastro-esophageal junction. The biasing structure imparts pressure against the wall of the patient's stomach adjacent the gastro-esophageal junction. | 01-05-2012 |
20120010556 | Long-Term Implantable Arterio-Venous Shunt Device - A long-term implantable arterio-venous shunt device is provided that can be used as a therapeutic method. The shunt device is implanted between an artery and a vein, preferably between the aorta and the inferior vena cava. The shunt device decreases the systemic vascular resistance and allows a blood flow rate through the shunt device of at least 5 ml/min after the implantation. The blood flow rate could be controlled either via an open loop or a closed loop control means. The shunt device could also be a self-adjustable shunt device to self-adjust its structure to control the blood flow rate through its lumen. Based on the effects of the shunt device to the respiratory, cardiac and circulatory system, the implantable shunt device could be beneficial as a therapy to patients with problems or conditions related to these systems. | 01-12-2012 |
20120029414 | Transcutaneous telemetry of cerebrospinal fluid shunt programmable-valve pressure using near-infrared (NIR) light - An improvement for a programmable valve system of the type implanted in a patient and used to divert cerebrospinal fluid (CSF) from an intraventricular space to a terminus such as the peritoneal cavity. Such system includes means for establishing a flow path for the CSF to the terminus, which flow path includes a normally closed valve and means for adjusting the opening pressure of the valve in order to regulate the quantity of CSF diverted. The improvement enables an operator to be apprised of the actual opening pressure setting of the valve. A sensor is implantable at the patient and responds to the actual opening pressure setting, by generating an NIR telemetry signal indicative of the actual setting. This signal is transcutaneously transmitted through the skin of the patient to an external point. The telemetry signal is processed to produce observer intelligible data indicating the opening pressure setting of the valve. | 02-02-2012 |
20120046595 | IMPLANTABLE ADJUSTABLE VALVE - A valve unit capable of being implanted in a patient and having adjustable performance settings, such as pressure settings and/or flow control, to regulate passage of a bodily fluid. A casing defines a port for the bodily fluid, and a valve mechanism positioned at the port includes a movable valve member. The valve unit further includes a rotor disposed at a first location in the casing and having an axle which turns about an axis of rotation. The rotor defines a plurality of arcuate, radially flat cam surfaces. Each cam surface occupies an arc about the axis of rotation. A spring arm unit is disposed at a second location in the casing having a cam follower arm in slidable contact with the cam surfaces of the rotor and having a resilient spring element applying a closing effect with the movable valve member to establish a performance setting for the valve unit. Sufficient rotation of the rotor to change the cam surface in contact with the cam follower alters the closing effect with which the valve member moves relative to the port and thereby alters the performance setting of the valve unit. | 02-23-2012 |
20120046596 | PROGRAMMABLE SHUNT WITH ELECTROMECHANICAL VALVE ACTUATOR - Devices and methods for regulating and directing bodily fluids from one region of a patient to another region are disclosed. In general, an apparatus is provided that can include an implantable shunt system and a system controller. The implantable shunt system can have an adjustable valve for regulating the flow of fluid, a sensor element for measuring a physiological characteristic of a patient, and an electromechanical valve actuator that can be adapted to adjust a resistance of the valve. The implantable shunt system can be in electrical communication with the system controller. The system controller can generally be adapted to receive a physiological characteristic of the patient and operate the electromechanical valve actuator to adjust a resistance of the valve. The apparatus can also include an external programming device that is in communication with the system controller. | 02-23-2012 |
20120059305 | ARTERIOVENOUS SHUNT WITH INTEGRATED SURVEILLANCE SYSTEM - A hemodialytic angioacess device for implantation in dialysis patients, comprising an arteriovenous (AV) shunt, anastomotic valves that connect the AV shunt to blood vessels, a valve control system and an integrated surveillance system that measures flow conditions in the blood vessels at the AV shunt, preferably when the valves are closed and the patient is not undergoing dialysis treatment. The flow condition data, which may include data representing the flow rate, pressure, volume and velocity of blood flowing through the vessels, is stored in a memory and transmitted to a health care provider or technician on demand. The data can be used to calculate and monitor important physiological parameters, such as compliance and resistance, for the blood vessels, and help detect and identify dangerous conditions, such as turbulence and stasis, which can contribute to AV shunt failure, vessel injury and other serious complications for the patient. | 03-08-2012 |
20120078159 | MULTI-LUMEN VENTRICULAR DRAINAGE CATHETER - A shunt includes a housing having an inlet, an outlet and a flow control mechanism disposed within the housing. A ventricular catheter is connected to the inlet of the housing. The catheter has a longitudinal length, a proximal end, a distal end, and an inner lumen extending therethrough. The inner lumen of the catheter includes at least two lumens at the distal end and has only one lumen at the proximal end. The catheter has one slit and aperture corresponding to each of the at least two lumens located at the distal end of the catheter. | 03-29-2012 |
20120089072 | SUBCONJUNCTIVAL CONFORMER DEVICE AND USES THEREOF - The present invention provides a device for use in an eye with elevated intraocular pressure or glaucoma, the device comprising a subconjunctival conformer shaped to conform to the eye wall and a fluid director that directs or facilitates the flow of intraocular fluid out of the eye and into the subconjunctival or retrobulbar space. The present invention also provides a method of lowering intraocular pressure using the device of the present invention. | 04-12-2012 |
20120089073 | GLAUCOMA DRAINAGE DEVICE AND USES THEREOF - In one aspect, the present invention provides an implant device for use in an eye with elevated intraocular pressure or glaucoma. In another aspect, the present invention provides a method for lowering intraocular pressure and/or treating a condition associated with elevated intraocular pressure using the implant device of the present invention. | 04-12-2012 |
20120095384 | STOMACH-SPANNING GASTRIC IMPLANTS - A variety of passive intragastric implant devices for obesity treatment are disclosed. Such passive implants do not autonomously change shape, but instead react within the stomach to induce satiety. The implants may take up volume within the stomach, thus reducing the digestive capacity. Additionally, the implants may contact areas within the stomach, such as the cardia surrounding the esophageal sphincter, to stimulate satiety-inducing nerves. Also, a number of implants slow gastric emptying by blocking or otherwise impeding flow through the pyloric sphincter. Other implants delay digestion by providing a duodenal sleeve. A number of implants combine two or more of these satiety-inducing features. Methods of implant are disclosed including compressing the implants within a delivery tube and transorally advancing the implants through the esophagus to be deployed within the stomach. Removal of the implants occurs in the reverse. | 04-19-2012 |
20120095385 | INTRAGASTRIC IMPLANTS WITH DUODENAL ANCHORS - Intragastric fluid transfer devices and related methods for operation thereof are disclosed. The intragastric fluid transfer devices and related methods are intended to assist a patient in maintaining a healthy body weight by stimulating the inner stomach walls and/or the inner duodenum walls. Features of the intragastric fluid transfer device include insertion of the devices transorally and without invasive surgery, without associated patient risks of invasive surgery, and without substantial patient discomfort. The life span of these intragastric fluid transfer devices may be material-dependent upon long-term survivability within an acidic stomach, but is intended to last one year or longer. | 04-19-2012 |
20120130301 | INTRA-ATRIAL IMPLANTS TO DIRECTIONALLY SHUNT BLOOD - Several unique intracardiac pressure vents, placement catheters, methods of placement and methods of treating heart failure are presented. The intracardiac pressure vents presented allow sufficient flow from the left atrium to the right atrium to relieve elevated left atrial pressure and resulting patient symptoms but also limit the amount of flow from the right atrium to the left atrium to minimize the potential for thrombus or other embolic material from entering the arterial circulation. | 05-24-2012 |
20120143118 | OPTIC NERVE IMPLANTS - Methods and devices for delivering therapeutic substances into the eye. An implant containing the therapeutic substance is implanted at least partially within the optic nerve and the therapeutic substance then elutes from the implant. The implant may have a lumen or it may be solid. | 06-07-2012 |
20120165723 | METHODS FOR IMPLANTING A SOFT GEL SHUNT IN THE SUPRACHOROIDAL SPACE - The invention generally relates to methods for implanting a soft gel shunt in the suprachoroidal space. In certain embodiments, methods of the invention involve inserting into the eye a hollow shaft configured to hold a soft gel intraocular shunt, deploying the soft gel shunt from the hollow shaft such that the shunt forms a passage from the anterior chamber of the eye to the suprachoroidal space of the eye, and withdrawing the hollow shaft from the eye. | 06-28-2012 |
20120184892 | APPARATUS AND METHODS FOR TREATING EXCESS INTRAOCULAR FLUID - An ocular drainage system is provided for treating diseases that produce elevated intraocular pressures, such as glaucoma, wherein the system includes an implantable device and an external control unit. The implantable device includes a non-invasively adjustable valve featuring at least one deformable tube and a disk rotatably mounted within a housing, such that rotation of the disk using the external control unit causes the disk to apply a selected amount of compression to the deformable tube, thereby adjusting the fluidic resistance of the deformable tube and regulating the intraocular pressure. | 07-19-2012 |
20120184893 | ANCHORS AND METHODS FOR INTESTINAL BYPASS SLEEVES - A gastrointestinal device for implanting within a pylorus, a duodenal bulb, and a duodenum of a patient's gastrointestinal tract includes an expandable structure including a proximal portion having a plurality of spring arms and a distal portion having a plurality of spring arms, the proximal and distal portions coupled by a rigid central cylinder having a diameter capable of fitting within the pylorus and having a length greater than a width of the pylorus. An intestinal bypass sleeve is coupled to at least one of the proximal and distal portions of the expandable structure and having a length sufficient to extend at least partially into the duodenum. In the expanded configuration, the proximal portion has a diameter larger than a maximum opening diameter of the pylorus and further wherein, in the expanded configuration, the distal portion has a diameter larger than a maximum opening diameter of the pylorus. | 07-19-2012 |
20120191030 | EUSTACHIAN TUBE DEVICE - A device stenting the Eustachian tube is inserted through the nasopharynx and provides enhanced ventilation and drainage to the middle ear. Also provided is a method for inserting the device into the Eustachian tube and through the isthmus of a human subject. | 07-26-2012 |
20120197177 | ADJUSTMENT FOR HYDROCEPHALUS SHUNT VALVE - An implantable medical device is disclosed that includes a valve seat and a valve member movable with respect to the valve seat. An adjustment circuit assembly includes a resistive element that is coupled to the valve member and operable to position the valve member relative to the valve seat so as to alter the pressure setting in response to a current applied to the resistive element. | 08-02-2012 |
20120197178 | READING AND ADJUSTING TOOL FOR HYDROCEPHALUS SHUNT VALVE - A reading and adjustment tool for use with a valve having a pressure or flow setting adjustable to a plurality of pressure or flow settings is disclosed. The tool includes a signal generator and an excitation coil coupled to the signal generator. The signal generator includes an adjustment interface configured to generate an adjustment signal to adjust the pressure or flow setting and a reading interface to generate a reading signal to read the pressure or flow setting of the valve. At least one excitation coil is connected to the signal generator and configured to generate an oscillating electromagnetic field based on one of the adjustment signal and reading signal. A sense coil can include two portions positioned on either side of the at least one excitation coil to determine the pressure or flow setting of the valve. | 08-02-2012 |
20120209165 | APPARATUS AND METHODS FOR TREATING INTRACORPOREAL FLUID ACCUMULATION - A fluid management system for the treatment of ascites, pleural effusion or pericardial effusion is provided including an implantable device including a pump, control circuitry, battery and transceiver; a charging and communication system configured to periodically charge the battery and communicate with the implantable device to retrieve performance data; and monitoring and control software, suitable for use with conventional personal computers, for configuring and controlling operation of the implantable device and charging and communication system. The implantable device includes a number of features that provide automated movement of fluid to the bladder with reduced risk of clogging, with no patient involvement other than occasional recharging of the battery of the implantable device. The monitoring and control software is available only to the treating physician, such that the physician interacts with the implantable device via the charging and communication system. | 08-16-2012 |
20120226215 | Systems and Methods for Controlling Cerebrospinal Fluid in a Subject's Ventricular System - A system for draining excess cerebrospinal fluid (CSF) from the head of a subject includes a drainage shunt and a valve assembly that selectively permits the shunt to drain CSF. The valve assembly also compensates for multiple factors that can affect the subject's intracranial pressure (ICP) and compliance, and could otherwise lead to CSF over-drainage or other undesirable conditions. | 09-06-2012 |
20120232460 | INTRALUMINAL SLEEVE WITH ACTIVE AGENTS - An intraluminal sleeve system is provided, which generally includes an intraluminal sleeve capable of dispensing an active agent to a patient, for example, a metabolic agent or satiety inducing agent. The intraluminal sleeve may be structured to contain the active agent and permit controlled release of the active agent to the patient while the intraluminal sleeve is positioned within the patient's intestine. Methods for treating obesity are also provided which include positioning an intraluminal sleeve in a patient's intestine, the intraluminal sleeve being capable of dispensing an active agent to the patient. In one embodiment, the active agent may be contained in a reservoir and dispensed to a portion of the patient's body. | 09-13-2012 |
20120232461 | SYSTEMS AND METHODS OF CONTROLLING FLOW OF BODILY FLUIDS - Systems and methods to regulate flow of bodily fluids, such as cerebrospinal fluid (CSF), including a fluid chamber, an inlet port to receive the bodily fluid into the fluid chamber, an outlet port to remove the bodily fluid from the chamber, and a pressure element to regulate the amount of fluid flowing from the inlet port to the outlet port based on a pressure of the bodily fluid against an absolute pressure reference. | 09-13-2012 |
20120232462 | IMPLANTABLE HYDROCEPHALUS SHUNT SYSTEM - An implantable hydrocephalus shunt system. The abstract of the disclosure is submitted herewith as required by 37 C.F.R. §1.72( | 09-13-2012 |
20120253258 | OCULAR SYSTEM WITH ANCHORING IMPLANT AND THERAPEUTIC AGENT - Ocular implants, delivery devices and methods for treating ocular disorders are disclosed. One method involves inserting an implant on one side of an eye. The implant has an anchor on a distal end portion and an outlet opening that is disposed proximal of the anchor. The implant is advanced across the eye to the other side of the eye. The anchor is inserted into eye tissue on the other side of the eye. A therapeutic agent is eluted using the implant. | 10-04-2012 |
20120253259 | MODULAR GASTROINTESTINAL PROSTHESES - A modular system for therapy within a gastrointestinal system. The system includes anchoring or attachment functionality embodied in a low-profile implant technology and removable therapy components, which can be reversibly attached to these low-profile implants to accomplish various therapies. This modular design allows the physician to tailor the therapy to the patient's needs. The modular system has the potential to create conduits for diversion and/or restriction of food and organ secretions and to facilitate the treatment of metabolic disorders such as obesity and T2DM. | 10-04-2012 |
20120253260 | GASTROINTESTINAL PROSTHESES - A system for therapy within a gastrointestinal system includes anchoring or attachment functionality embodied in a low-profile implant technology and removable therapy components, which can be reversibly attached to these low-profile implants to accomplish various therapies. This design allows the physician to tailor the therapy to the patient's needs. The system has the potential to create conduits for diversion and/or restriction of food and organ secretions and to facilitate the treatment of metabolic disorders such as obesity and T2DM. | 10-04-2012 |
20120259264 | SYSTEMS FOR INDUCING FLUID FLOW TO STIMULATE TISSUE GROWTH - Provided are apparatuses, systems, and methods for treating tissue at a tissue site in a mammal that includes a scaffold adapted to be disposed adjacent to the tissue site and to be fluidly coupled to a blood vessel of the mammal for receiving blood therefrom. Additionally, a scaffold is provided that includes a charged surface comprising a streaming potential. | 10-11-2012 |
20120259265 | Regulated Gravity-Based Cerebral Spinal Fluid Drainage Device - Portable external gravity-based devices and methods for regulating cerebral spinal fluid drainage from brain, tissue or organs of a patient, and methods for reducing secondary brain injury to a patient by externally regulating the amount of gravity-based cerebral spinal fluid drainage from brain or spine are provided by this invention. | 10-11-2012 |
20120277657 | BICORPORAL PARTIALLY SUBCUTANEOUS POSITIVE DISPLACEMENT PUMP - The present general inventive concept relates to systems and methods for moving a predetermined volume of fluid from one location within a subject's body to another location within a subject's body. The system includes an internal and an external component with no physical connection between. The external component includes the power and control systems while the internal component includes a positive displacement fluid pump that restricts backflow and displaces a controlled volume of fluid over time or per cycle. | 11-01-2012 |
20120277658 | URETHRAL CATHETERLESS RADICAL PROSTATECTOMY - A method and device for facilitating the anastomotic healing of a patient after a radical prostatectomy surgical procedure, without a urethral catheter, comprising the steps of performing a radical prostatectomy, fixedly positioning a splinting element between the urethra and the bladder, across the urethral opening, placing the splinting element during the performing of the radical prostatectomy and prior to surgical closure. The fixed positioning is effected from a position within the bladder with anchoring the splinting element in position relative to the interior of the bladder, setting a separate urine drainage tube, and removing the splinting element, after anastomotic healing, with a retrieval element on the splinting element or with dissolving of the splinting element. | 11-01-2012 |
20120289880 | Methods, Devices, Kits and Systems for Defunctionalizing the Cystic Duct - The application discloses devices, systems, kits and methods for treating biliary disease. Devices comprise, for example, a component configurable for deployment between within a cystic duct of a patient which has a proximal end and a distal end. In some embodiments, a lumen may also extend therethrough. | 11-15-2012 |
20120289881 | System and Implantable Device for Treating Chronic Kidney Disease - An implantable dialysis device with a related medical system for intracorporeal dialysis and ultrafiltration of blood, and methods of use are described. The medical system includes an extracorporeal module, a cutaneous module, and an implantable module. Features of the implantable module facilitate delivery and flow of blood and dialysate through the medical system. A filter pack within the implantable module performs dialysis and ultrafiltration of blood. System cleansing is also described. | 11-15-2012 |
20120289882 | INTRA-ATRIAL IMPLANTS HAVING VARIABLE THICKNESSES TO ACCOMODATE VARIABLE THICKNESS IN SEPTUM - The invention is a septal implant that can accommodate variable thicknesses of the patient's atrial septum as well the variable thicknesses of septums across a population. The invention is able to accomplish this result by having flexible annular flanges that define a gap into which the septum fits. Due to the flexible nature of the annular flanges, the gap is adjustable. | 11-15-2012 |
20120289883 | Implantable Intraocular Pressure Drain - An implanted parylene tube shunt relieves intra-ocular pressure. The device is implanted with an open end in the anterior chamber of the eye, allowing excess fluid to be drained through the tube out of the eye. In one embodiment, only a first end of the tube implanted into the anterior chamber of the eye is open. Intra-ocular pressure (IOP) is then monitored, for example utilizing an implanted sensor. When IOP exceeds a critical valve, a practitioner intervenes, puncturing with a laser a thinned region of the tube lying outside the eye, thereby initiating drainage of fluid and relieving pressure. In accordance with alternative embodiments, the both ends of the tube are open, and the tube includes a one-way valve configured to permit drainage where IOP exceeds the critical value. The tube may include projecting barbs to anchor the tube in the eye without the need for sutures. | 11-15-2012 |
20120296257 | BILIARY SHUNTS, DELIVERY SYSTEMS, METHODS OF USING THE SAME AND KITS THEREFOR - The application discloses devices, systems, kits and methods for treating biliary disease. Device comprise, for example, a component configured for deployment between a gallbladder and location within a gastrointestinal tract of a patient which has a proximal end and a distal end with a lumen extending therethrough. A method of deploying the device can be achieved by, for example, creating a duct or fistula between a gallbladder lumen and a portion of a gastrointestinal tract; and providing for drainage from the gallbladder to the gastrointestinal tract. | 11-22-2012 |
20120296258 | Intraocular Pressure Sensor with External Pressure Compensation - An intraocular pressure sensor system has a first pressure sensor located in an anterior chamber of an eye and a remote pressure sensor located remotely from the first pressure sensor. The remote pressure sensor measures or approximates atmospheric pressure. A difference between readings from the first pressure sensor and the remote pressure sensor approximates intraocular pressure. | 11-22-2012 |
20120302937 | Programmable Device For Treating Over Drainage Due To Siphonic Effects In Hydrocephalus Shunt Systems - A valve assembly for adjusting the flow of bodily fluid from one part of a human body to another includes a body portion having a flow inlet and a flow outlet. A valve located in a flow path from the inlet to the outlet includes a valve seat and a closing element that is adapted to seal against the valve seat. A carrier element is mounted within the body portion and has a plurality of pockets. Each pocket houses a respective preload element, wherein each preload element is of a different weight from that of the other preload elements. The carrier element is moveable relative to the body portion so as to align a preload element of a desired weight with the closing element. The self weight of the chosen preload element applies a preload to the closing element dependent on the orientation of the valve assembly. | 11-29-2012 |
20120302938 | DRAINAGE SYSTEMS FOR EXCESS BODY FLUIDS AND ASSOCIATED METHODS - Drainage systems for excess body fluids and associated methods are disclosed herein. A body fluid drainage system in accordance with an embodiment of the present technology, for example, can include a catheter having an exterior surface, a proximal portion, and a distal portion. The body fluid drainage system can further include a valve device, a pressure sensor, and a controller operatively coupled to the valve device and the pressure sensor. The valve device can include an actuator positioned over the exterior surface of the catheter. The actuator is movable between an open position that allows body fluid flow through the catheter, a closed position that at least substantially obstructs the body fluid flow through the catheter, and intermediate positions that partially obstruct the body fluid flow through the catheter. The controller can change the position of the actuator in response to a predetermined condition of the pressure sensor. | 11-29-2012 |
20120310138 | GASTROINTESTINAL IMPLANT DEVICE AND DELIVERY SYSTEM THEREFOR - A delivery system comprises a delivery catheter with a distal capsule which contains a scaffold, a valve and a sleeve in the retracted configuration. The delivery system includes a proximal expandable element provided by an inflatable proximal balloon and a distal expandable element provided by a distal balloon. The proximal balloon provides a temporary seal at the proximal side of the valve. The distal balloon provides a temporary distal seal between a distal olive and a distal end of the sleeve. An inflation fluid is introduced into the sleeve between the proximal and distal balloons the fluid causes the sleeve to expand axially to the expanded deployed configuration. When the sleeve is in the extended deployed configuration the distal balloon is deflated, allowing the olive to detach and travel distally. The rest of the delivery system can then be withdrawn proximally, leaving the implant device in situ. | 12-06-2012 |
20120310139 | ADJUSTABLE VALVE SETTING WITH MOTOR CONTROL - An implantable medical device is disclosed that includes a valve body and a valve rotor adjustable with respect to the valve body. A tool can be utilized to determine and control a position of the valve rotor with respect to the valve body. The tool can include a valve body position reader, a valve rotor position reader and a valve rotor position controller to determine a valve setting for the device and adjust the valve setting as desired. | 12-06-2012 |
20120316487 | METHOD OF TREATING COPD WITH ARTIFICIAL ARTERIO-VENOUS FISTULA AND FLOW MEDIATING SYSTEMS - A method for treatment of COPD, hypertension, and left ventricular hypertrophy, and chronic hypoxia including creation of an artificial arterio-venous fistula and installation of a flow mediating device proximate the fistula. The flow mediating device is operated to limit flow as medically indicated to provide the optimum amount of bypass flow. | 12-13-2012 |
20120323160 | UPPER STOMACH GASTRIC IMPLANTS - A variety of passive intragastric implant devices for obesity treatment are disclosed. Such passive devices may not autonomously change shape, but instead react within the stomach to induce satiety. The devices may provide slowed entry into the stomach, thus reducing the intake capacity. Additionally, the devices may contact areas within the stomach, such as the cardia surrounding the esophageal sphincter, to stimulate satiety-inducing nerves. Some devices combine two or more of these satiety-inducing features. Methods of implant are disclosed including compressing the devices within a delivery tube and transorally advancing the devices through the esophagus to be deployed within the stomach. Removal of the devices occurs in the reverse. The implants are formed of materials that permit the implant to be compressed into a substantially linear transoral delivery configuration and that will resist degradation over a period of at least six months within the stomach. | 12-20-2012 |
20120323161 | Electrokinetic Actuator to Titrate Fluid Flow - An electrokinetic actuator for fluid flow titration including two chambers separated from one another by a porous dielectric disposed therebetween. A plurality of electrodes are disposed about a perimeter of the first and second chambers. Polar electrolyte disposed within the actuator is able to pass through the porous dielectric between the first and second chambers upon the application of an electric field or electric potential to the plural electrodes. A mechanical valve actuation mechanism connected to the second chamber allows for fine titration of fluid flow using electro-osmosis, including full-flow and/or complete cut-off. The polar electrolyte is isolated to prohibit intermixing with a fluid being titrated such as cerebrospinal fluid. | 12-20-2012 |
20130006166 | APPARATUS FOR TREATING OBESITY BY EXTRACTING FOOD - The present invention is directed to an apparatus and method for treating obesity. A tube is positioned that passes through a patient's abdominal wall into the upper digestive system of the patient. The patient is allowed to carry out his/her everyday affairs including ingesting food. After the patient has ingested food, the food is extracted by pumping it out of the upper digestive system through the tube. The present invention is less invasive than current surgical procedures for reducing weight and allows patients to live a normal and active lifestyle without experiencing adverse side effects. | 01-03-2013 |
20130012863 | RESTRICTIVE AND/OR OBSTRUCTIVE IMPLANT SYSTEM FOR INDUCING WEIGHT LOSS - The present application describes an implant system useable for positioning an implant device such as a device useful for restricting passage of ingested food into the stomach. In one embodiment, the disclosed system includes a plurality of anchors that may be coupled to tissue within the stomach, or to a tissue tunnel formed by plicating stomach wall tissue. The anchor includes a loop. During use, the implant device is inserted through the loop and expanded such that it retains its position within the loop until removed. Instruments for implanting and explanting the implant device are also described. | 01-10-2013 |
20130018297 | DISTAL PERFUSION SHEATH - A distal perfusion sheath (DPS) is provided for cases where blood perfusion is needed for downstream arteries (distal) to the insertion point of the DPS within the target artery. The ability to provide distal perfusion with the DPS allows the DPS to be positioned in the target artery for long periods without causing lack of blood flow (ischemia) to an extremity that the target artery supplies. In embodiments, the DPS can still be used for surgical arterial access while allowing blood flow downstream. In addition, embodiments of the DPS configured with longer perfusion shunts can allow a contra-lateral extremity downstream to a large DPS to have blood flow while the sheath is in place. | 01-17-2013 |
20130030351 | DELIVERY DEVICES AND METHODS FOR GASTROINTESTINAL IMPLANTS - Several gastrointestinal surgery procedures are effective as treatments for metabolic disorders such as obesity and diabetes. Minimally invasive procedures including intra-luminal gastrointestinal implants have been proposed to mimic the anatomical, physiological and metabolic changes achieved by these procedures. Many of these designs include long sleeve like elements that prevent contact of food with the walls of the small intestine. It is desirable to have simple delivery systems that can place these implants under endoscopic guidance. However, in order to anchor these sleeve elements safely and reliably, the inventors have previously disclosed anchoring means that anchor the sleeves at the junctions of the stomach and the intestine or the stomach and esophagus. | 01-31-2013 |
20130060186 | DEVICE AND METHOD FOR ESTABLISHING AN ARTIFICIAL ARTERIO-VENOUS FISTULA - A shunt rivet for implantation in the aorta and inferior vena cava to treat chronic obstructive pulmonary disease, and a method of treating chronic obstructive pulmonary disease. | 03-07-2013 |
20130066253 | ADJUSTMENT FOR HYDROCEPHALUS SHUNT VALVE - An implantable medical device is disclosed that includes a valve seat and a valve member movable with respect to the valve seat. An adjustment circuit assembly includes a resistive element that is coupled to the valve member and operable to position the valve member relative to the valve seat so as to alter the pressure setting in response to a current applied to the resistive element. | 03-14-2013 |
20130085439 | DEVICE TO ENCOURAGE BLOOD CIRCULATION BETWEEN DIALYSIS - A vascular access system includes a vascular access device and a portable recirculation device. The vascular access device defines at least one lumen and is configured and dimensioned to be positioned within a blood vessel of a patient. The recirculation device includes a housing defining a channel having an inlet port and an outlet port for passage of blood through the channel. The channel includes a pump for circulating blood through the vascular access device. | 04-04-2013 |
20130085440 | Selectable Varied Control Valve Systems For IOP Control Systems - A selectable IOP valve for implantation in an eye of a patient controls IOP and/or bleb pressure. The valve includes a drainage tube configured to convey aqueous from an anterior chamber of an eye and includes a selectable flow control valve in fluid communication with the drainage tube and configured to control flow rates of the aqueous. The valve system includes a plurality of flow control pathways arranged to operate in parallel with each other, each of the flow control pathways being in communication with an entry port to the valve system. A flow control mechanism controls aqueous flow through the pathways. Methods and systems are also disclosed. | 04-04-2013 |
20130085441 | SHUNT VALVE FOR TREATMENT OF HYDROCEPHALUS | 04-04-2013 |
20130096483 | Active Bimodal Valve System For Real-Time IOP Control - An IOP control system provides drainage from an anterior chamber of the eye to a drainage location at the eye. The system has a valve with an open flow position and a closed zero flow position. A sensor system includes a first sensor arranged to detect a first pressure representative of IOP. A controller receives data representing the detected pressure from the sensor system and compares the data to an upper pressure threshold and a lower pressure threshold to determine whether to change the state of the valve system in a bimodal fashion. | 04-18-2013 |
20130096484 | IMPLANTABLE ADJUSTABLE VALVE - A valve unit capable of being implanted in a patient and having adjustable performance settings, such as pressure settings and/or flow control, to regulate passage of a bodily fluid. A casing defines a port for the bodily fluid, and a valve mechanism positioned at the port includes a movable valve member. The valve unit further includes a rotor disposed at a first location in the casing and having an axle which turns about an axis of rotation. The rotor defines a plurality of arcuate, radially flat cam surfaces. Each cam surface occupies an arc about the axis of rotation. A spring arm unit is disposed at a second location in the casing having a cam follower arm in slidable contact with the cam surfaces of the rotor and having a resilient spring element applying a closing effect with the movable valve member to establish a performance setting for the valve unit. Sufficient rotation of the rotor to change the cam surface in contact with the cam follower alters the closing effect with which the valve member moves relative to the port and thereby alters the performance setting of the valve unit. | 04-18-2013 |
20130102951 | CSF SHUNT FLOW ENHANCER, METHOD FOR GENERATING CSF FLOW IN SHUNTS AND ASSESSMENT OF PARTIAL AND COMPLETE OCCLUSION OF CSF SHUNT SYSTEMS - An apparatus capable of generating flow in cerebrospinal fluid (CSF) shunt systems by vibrating the shunt, tubing or shunt valve dome, or applying cyclical pressure to the various parts of the shunt system. A method of generating flow and method of using the apparatus in shunt patency assessment, for example, hydraulic resistance assessment, is also disclosed. The apparatus allows, in conjunction with a thermal dilution method or radionuclide method, a quick CSF shunt patency assessment based upon CSF shunt resistance and not upon CSF flow or intracranial pressure (ICP) separately. This provides a more objective measure of shunt obstruction compared to other methods. Furthermore, the apparatus can be used to enhance flow in shunts, identify partial occlusion before symptoms occur, differentiate between patent, partially-occluded and occluded shunts. The apparatus can be used to generate flow in shunts if there is a need to lower ICP or move drugs administered via an injection chamber or a shunt dome. | 04-25-2013 |
20130131576 | CATHETER ASSEMBLY FOR USE WITH SHUNT SYSTEMS AND METHOD OF USING SAME - A catheter assembly for inserting in a fluid filled space in a body includes a main body having a first end portion and a second end portion. The first end portion is positionable within the fluid filled space and the second end portion is adapted to extend outward from the fluid filled space when the first end portion is positioned within the fluid filled space. The catheter assembly also includes a catheter tip that is connected to the second end portion. The catheter tip includes a housing having a cavity defined therein. The catheter tip also includes a rotating element positioned within the cavity. The rotating element is configured to rotate within the cavity to facilitate movement of the first end portion of the main body within the fluid filled space. | 05-23-2013 |
20130131577 | UVEOSCLERAL DRAINAGE DEVICE - An ophthalmic shunt implantable in an eye having an elongate body and a branched conduit for conducting aqueous humor from an anterior chamber of the eye to the suprachoroidal space of the eye and the subconjunctival space, and a plate extending from an upper surface of the elongate body. | 05-23-2013 |
20130144202 | Bubble-Driven IOP Control System - An intraocular pressure control system for implantation in an eye of a patient to provide drainage from an anterior chamber of the eye to a drainage location at the eye includes a drainage tube and a valve system arranged to control drainage flow between the anterior chamber and the drainage site, the valve system being configured to control fluid flow using an electrolysis process and closed loop feedback from pressure sensors able to determine: flow rate, TOP, bleb pressure, and internal valve pressure. | 06-06-2013 |
20130144203 | Methods And Conduits For Flowing Blood From A Heart Chamber To A Blood Vessel - Disclosed is a conduit that provides a bypass around an occlusion or stenosis in a coronary artery. The conduit is a tube adapted to be positioned in the heart wall to provide a passage for blood to flow between a heart chamber and a coronary artery, at a site distal to the occlusion or stenosis. The conduit has a section of blood vessel attached to its interior lumen which preferably includes at least one naturally occurring one-way valve positioned therein. The valve prevents the backflow of blood from the coronary artery into the heart chamber. | 06-06-2013 |
20130150773 | Glaucoma Active Pressure Regulation Shunt - In various embodiments, a glaucoma shunt may include a tube having an anterior portion (with an opening) and a posterior portion. The glaucoma shunt may include a valve, inside the tube, coupled to a drainage portion. The tube may be configured to couple to a first portion of an eye and the drainage portion may be configured to couple to a second portion of the eye. In some embodiments, the drainage portion may be configured to move the valve relative to the tube such that when the eye expands, the valve moves away from the opening in the anterior portion of the tube to increase fluid flow. The drainage portion may further be configured to move the valve relative to the tube such that when the eye contracts, the valve moves toward the opening in the anterior portion of the tube to decrease fluid flow. | 06-13-2013 |
20130150774 | Active Drainage Systems With Pressure-Driven Valves and Electronically-Driven Pump - An IOP control system for implantation in an eye of a patient is disclosed. The IOP control system includes a drainage tube configured to convey aqueous humor from an anterior chamber of an eye and includes a pressure-driven valve system in fluid communication with the drainage tube and configured to control flow rates of the aqueous humor. The valve system includes a plurality of pressure-driven valves arranged to operate in cooperation with each other. The IOP control system may include an electronic pump system to further regulate flow. | 06-13-2013 |
20130150775 | Multilayer Membrane Actuators - An IOP control device for implantation in an eye of a patient is disclosed. The device includes a housing and a multilayer membrane. The housing is sized for implantation into the eye and includes an entrance port and an exit port. The membrane is anchored within the housing to form a flow control chamber on a first side and a fluid flow passageway on a second opposing side of the membrane. The chamber is arranged to contain a gas creating a chamber pressure, and the membrane is configured to affect flow through the passageway from the entrance port to the exit port by deflecting in response to changes in the chamber pressure. The membrane comprises a first layer having a higher permeability and a higher flexibility than the second layer, which is disposed adjacent the first layer and restricts the diffusion of gas in the chamber through the membrane. | 06-13-2013 |
20130150776 | Glaucoma Drainage Devices Including Vario-Stable Valves and Associated Systems and Methods - Glaucoma drainage devices including vario-stable valves and associated systems and methods are disclosed. A glaucoma drainage device includes a drainage lumen and a valve system coupled to the drainage lumen to control the flow of fluid through the drainage lumen. The valve system includes an adjustable valve with a diaphragm that is in communication with the drainage lumen and is movable to occupy varying amounts of the drainage lumen. In some embodiments, the valve system is maintained in a desired position without the use of power such that power is only needed when changing a position of the adjustable valve. | 06-13-2013 |
20130150777 | Glaucoma Drainage Devices Including Vario-Stable Valves and Associated Systems and Methods - Glaucoma drainage devices including vario-stable valves and associated systems and methods are disclosed. A glaucoma drainage device includes a drainage lumen and a valve system coupled to the drainage lumen to control the flow of fluid through the drainage lumen. The valve system includes an adjustable valve with a diaphragm that is in communication with the drainage lumen and is movable to occupy varying amounts of the drainage lumen. In some embodiments, the valve system is maintained in a desired position without the use of power such that power is only needed when changing a position of the adjustable valve. | 06-13-2013 |
20130150778 | Separation of Gas and Liquid in Membrane Valves - A drainage device for implantation in an eye of a patient to treat an ocular condition is disclosed. The drainage device includes a housing, a multi-compartment flow control chamber, and a membrane. The housing includes an entrance port and an exit port connected by a fluid flow passageway. The membrane is disposed between the fluid flow passageway and the multi-compartment flow control chamber, which includes a first compartment and a second compartment in fluid communication with each other. The first and second compartments are structurally arranged to limit contact of gas with the membrane, which is disposed between the fluid flow passageway and first compartment. The membrane is configured to affect flow through the fluid flow passageway by deflecting in response to pressure in the flow control chamber. | 06-13-2013 |
20130150779 | Active Drainage Systems with Dual-Input Pressure-Driven Valves - A pressure-driven valve is disclosed. The valve includes a housing and a flow control portion disposed within the housing. The housing includes a fluid inlet and a fluid outlet. The flow control portion has a first side subject to fluid flow pressure in a fluid flow channel, and a second side subject to an outlet pressure representative of pressure at the fluid outlet. The flow control portion is deformable to increase and decrease flow through the fluid flow channel based on pressure differentials between the fluid flow pressure, a tube pressure, and the outlet pressure. In some instances, the flow control portion comprises a flow control membrane and a radially-fluctuating pressure tube attached to the periphery of the membrane. | 06-13-2013 |
20130158465 | APPARATUS AND METHOD FOR TREATING OCCLUDED INFECTION COLLECTIONS OF THE DIGESTIVE TRACT - A device and method for treating an occluded infection collection along the digestive tract with a stent delivered to an appendix, diverticulum or other anatomical structure of the digestive tract. A device and method to remove an obstruction from an occluded infection collection along the digestive tract with an obstruction removal device delivered to an appendix, diverticulum or other anatomical structure of the digestive tract. | 06-20-2013 |
20130165842 | METHODS AND DEVICES TO CURB APPETITE AND/OR REDUCE FOOD INTAKE - The present invention relates to methods and devices that help to curb appetite and/or reduce food intake. In one embodiment, the methods and devices of the present invention include a small intestinal/duodenal insert comprising an elongated member with at least one flow reduction element that can cause the stimulation of one or more biological signals of satiety. | 06-27-2013 |
20130178783 | METHODS AND DEVICES FOR INTRA-ATRIAL SHUNTS HAVING ADJUSTABLE SIZES - Devices and methods for treating heart disease by normalizing elevated blood pressure in the left and right atria of a heart of a mammal are disclosed. Devices may include an adjustable hydraulic diameter shunt portion which can be manually adjusted in vivo. Methods are provided for adjusting the flow rate of the devices in vivo. | 07-11-2013 |
20130178784 | METHODS AND DEVICES FOR INTRA-ATRIAL SHUNTS HAVING ADJUSTABLE SIZES - Devices and methods for treating heart disease by normalizing elevated blood pressure in the left and right atria of a heart of a mammal are disclosed. Devices may include an adjustable hydraulic diameter shunt portion which can be manually adjusted in vivo. Methods are provided for adjusting the flow rate of the devices in vivo. | 07-11-2013 |
20130184632 | ARTERIAL-VENOUS SWITCHING - Methods and devices are provided for switching fluid flow through a body part, such as all or portions of an organ or extremity. In general, fluid inflow and fluid outflow vessels to at least a portion of a body part can be switched such that all fluid in at least a portion of the inflow and outflow vessels flows in an opposite direction. In other words, the fluid inflow vessel (or at least a portion thereof) becomes the fluid outflow vessel that receives fluid from a body part, and the fluid outflow vessel (or at least a portion thereof) becomes the fluid inflow vessel that delivers fluid to a body part. | 07-18-2013 |
20130184633 | METHODS, SYSTEMS, AND DEVICES FOR RESIZABLE INTRA-ATRIAL SHUNTS - Devices and methods for treating heart disease by normalizing elevated blood pressure in the left and right atria of a heart of a mammal are disclosed. Devices may include an adjustable hydraulic diameter and/or a removable and/or replaceable shunt portion. Devices may include absorbable materials, the absorption of which directly or indirectly causes alterations of the fluid flow capacities the devices. | 07-18-2013 |
20130184634 | METHODS AND DEVICES FOR INTRA-ATRIAL SHUNTS HAVING SELECTABLE FLOW RATES - Devices and methods for treating heart disease by normalizing elevated blood pressure in the left and right atria of a heart of a mammal are disclosed. The devices are adapted to permit fluid flow across the membrane in which the device is implanted at first rate, and at a second rate, wherein a difference between the first rate and the second rate is not solely dependent upon variations in blood pressure differential across the membrane due to the heart's pumping cycle. | 07-18-2013 |
20130184635 | OBESITY TREATMENT AND DEVICE - A method and apparatus are disclosed for treating obesity includes an artificial fistula created between gastrointestinal organs such as between the stomach and the colon. The method includes selecting an implant comprising a passageway having an internal lumen with an inlet end and an outlet end. The passageway is positioned passing through a first wall of first gastrointestinal organ (for example, passing through the wall of the stomach) and a second wall of a second gastrointestinal organ (for example, passing through the wall of the large intestine) with the inlet end disposed within an interior of the first gastrointestinal organ and with the outlet disposed within an interior of the second gastrointestinal organ. | 07-18-2013 |
20130197422 | FAILURE RESISTANT SHUNT - Drainage systems for excess body fluids and associated methods are disclosed herein. A body fluid drainage system in accordance with an embodiment of the present technology, for example, can include a catheter that has an exterior surface, a proximal portion, and a distal portion opposite the proximal portion. The body fluid drainage system can further include a valve device, a pressure sensor, and a controller operatively coupled to the valve device and the pressure sensor. The valve device can include an actuator positioned over the exterior surface of the catheter. The actuator is movable between an open position that allows body fluid flow through the catheter, a closed position that at least substantially obstructs the body fluid flow through the catheter, and intermediate positions that partially obstruct the body fluid flow through the catheter. The controller can change the position of the actuator in response to a predetermined condition of the pressure sensor. | 08-01-2013 |
20130197423 | METHODS AND APPARATUS FOR REDUCING LOCALIZED CIRCULATORY SYSTEM PRESSURE - The present invention is thus directed to methods and apparatus for decreasing pressure in a first portion of a vessel of the cardiac structure of a patient by implanting a shunt communicating with an area outside said first portion, whereby a volume of blood sufficient to reduce pressure in said first portion is released. | 08-01-2013 |
20130204176 | Arteriovenous Shunt Having a Moveable Valve - An arteriovenous shunt assembly including a shunt having a hollow bore between open first and second ends thereof and a valve slidably disposed through the hollow bore. The valve includes means for retaining the valve in a closed position or in any of various selected open positions that provide corresponding different rates of blood flow through the shunt assembly. In some embodiments, the AV shunt assembly is self-expandable from a collapsed tow-profile configuration employed during transluminal delivery. The valve position in the hollow bore may be adjusted in vivo by inflating a catheter balloon in a blood vessel to bear against an end of the valve. Methods for using the shunt assembly are also disclosed. | 08-08-2013 |
20130204177 | Active Drainage Systems with Dual-Input Pressure-Driven Values - A pressure-driven valve is disclosed. The valve includes a housing, a fluid flow channel, and a deflectable portion. The housing comprises a fluid inlet and a fluid outlet. The fluid flow channel extends between the fluid inlet and the fluid outlet. The deflectable portion is disposed within the housing, and defines a portion of the fluid flow channel. The deflectable portion is configured to deflect to increase and decrease a size of the fluid flow channel to regulate fluid flow from the fluid inlet to the fluid outlet. The deflectable portion is disposed and arranged to deflect as a result of pressure differentials between a reference pressure, a fluid flow channel pressure, and an outlet pressure representative of fluid pressure at the fluid outlet. | 08-08-2013 |
20130211311 | Pressure-Driven Membrane Valve for Pressure Control System - A control valve for a fluidic system is disclosed. The control valve comprises a housing and a flow control membrane is disclosed. The flow control membrane is anchored within the housing to form a reference chamber on a first side of the membrane and a fluid flow channel on a second opposing side of the membrane. The fluid flow channel selectively opens and closes to permit fluid to flow from the inlet to the outlet, and the membrane is configured to control flow through the channel from the inlet to the outlet by deflecting in response to pressure differentials of the reference chamber pressure and the fluid flow channel pressure acting across the membrane. | 08-15-2013 |
20130211312 | Prefilled Ocular Implants and Methods - A drainage device for implantation in an eye of a patient to treat an ocular condition includes a first tube configured to extend into an anterior chamber of the eye and convey aqueous humor from the anterior chamber. An exit portion is in fluid communication with the distal end portion. A passage extends between the distal portion of the first tube and the exit portion, with a liquid disposed in the passage. The implant may include a first seal associated with the distal end portion and a second seal associated with the exit portion to prevent drainage of the liquid through the exit portion. The implant may include an implant body disposed between the distal end portion and the exit portion, the passage extending through the implant body. The implant body may comprise a fluid-sensitive component in fluid communication with the passage that may be formed of a flexible membrane. | 08-15-2013 |
20130211313 | Corrugated Membrane Actuators - An IOP control valve is disclosed. The IOP control valve comprises a corrugated membrane and a housing including a fluid inlet and a fluid outlet. The corrugated membrane is anchored within the housing to form a reference chamber on a first side of the corrugated membrane and a fluid flow channel on a second opposing side of the membrane. The reference chamber has a reference chamber pressure representative of atmospheric pressure. The fluid flow channel can selectively increase and decrease in size to permit fluid to flow from the fluid inlet to the fluid outlet. The corrugated membrane is configured to affect flow through the fluid flow channel from the fluid inlet to the fluid outlet by deflecting in response to pressure differentials of the reference chamber pressure and the fluid flow channel pressure acting on the opposing sides of the corrugated membrane. | 08-15-2013 |
20130211314 | GLAUCOMA VALVE, A CASING FOR CONTAINING A GLAUCOMA VALVE, AND A GLAUCOMA DRAINAGE DEVICE COMPRISING THE VALVE AND/OR THE CASING - Various embodiments of the invention relate to a glaucoma valve, a casing for containing a glaucoma valve and a glaucoma drainage device comprising the glaucoma valve and/or the casing. The valve includes a flow channel having an inlet and an outlet and a valve member connected to the outlet of the flow channel. The valve member may be formed from a degradable polymer or a combination of degradable polymer and non-degradable polymer. Various embodiments of the invention relate to a glaucoma valve, the valve having a first flow channel. The interior of the first flow channel may be coated with a degradable polymer, such that in use, the polymer degrades to allow a greater flow of fluid through the flow channel. In some embodiments, the valve includes a second flow channel, which may be arranged in parallel to the first flow channel. The first flow channel may be completely sealed with the polymer such that in use, the polymer degrades to allow fluid to flow through the first flow channel. Various embodiments relate to a casing for containing a glaucoma valve. The casing may be formed from a degradable polymer, such as a biodegradable polymer. | 08-15-2013 |
20130218064 | Glaucoma Drainage Device with Pump - A glaucoma drainage device has a main drainage tube with a first end an anterior chamber of an eye and a second end in a drainage location. A bypass drainage tube is fluidly coupled to and in parallel with the main drainage tube. A pump is in communication with the bypass drainage tube. The pump comprises a first driver and a first flexible membrane enclosing a first chamber. A first check valve is located upstream from the pump, and a second check valve is located downstream from the pump. An active valve is located upstream from the first check valve. The active valve comprises a second driver and a second flexible membrane enclosing a second chamber. A third check valve is located between the active valve and the second end of the main drainage tube. A volume of the first chamber is changed to pump fluid from the anterior chamber. | 08-22-2013 |
20130226066 | Apparatus for monitoring cerebrospinal fluid drainage - An apparatus for monitoring CSF drainage is provided with a tubing having one end installed in a brain of a patient and the other end installed in an abdominal cavity of the patient for draining CSF from the brain to the abdominal cavity; an internal monitoring device disposed in the tubing proximate to the abdominal cavity, the internal monitoring device being for measuring fluid pressure of the CSF and regulating flow rate of the CSF; and an external processing device disposed externally of the patient, the external processing device being for wirelessly controlling the internal monitoring device by processing a fluid pressure signal and a flow rate signal both transmitted from the internal monitoring device, and by transmitting both a fluid pressure control signal and a flow rate control signal to the internal monitoring device. The external processing device includes a display for displaying processed data. | 08-29-2013 |
20130226067 | Arteriovenous Shunt Having Eccentric Anchor Stent - An arteriovenous shunt includes a self-expanding stent graft having a self-expanding anchor stent mounted eccentrically and externally about at least one end segment of the stent graft. A fluid passageway extends between open first and second ends of the shunt. The anchor stent has an expanded diameter greater than an expanded diameter of the stent graft. The expanded diameter of the stent graft is smaller than the artery or vein into which it is deployed. Methods of deploying the arteriovenous shunt are also disclosed, | 08-29-2013 |
20130226068 | WIRELESS SHUNTS WITH STORAGE - Devices and methods useful for storing and retrieving information related to a medical device such as an implantable valve or an implantable sensor are disclosed. An implantable valve can include a valve housing adapted to receive fluid flow therethrough between a valve inlet and a valve outlet. A valve assembly can be disposed within the valve housing and adapted to control a rate of fluid flowing through the valve housing. The implantable valve can also include a radio frequency identification (RFID) tag associated with the valve housing, adapted to store data, and including an antenna for communicating stored data to an external reading device. The RFID tag can store data related to, for example, a patient, a pressure setting of the valve assembly, and/or pressure sensor disposed within the valve. The RFID tag can also store an identifier that identifies the implantable valve, a pressure sensor disposed in the valve housing, a patient associated with the implantable valve, and/or patient clinical history. | 08-29-2013 |
20130245534 | INJECTABLE VALVE AND OTHER FLOW CONTROL ELEMENTS - Apparatus for controlling flow through a body lumen, the apparatus comprising:
| 09-19-2013 |
20130253409 | IMPLANTABLE FLUID MANAGEMENT DEVICE FOR THE REMOVAL OF EXCESS FLUID - A device for removing fluid from a first bodily cavity and for directing that fluid into a second bodily cavity while avoiding risks of infection and, in one embodiment, excessive dehydration of the first bodily cavity. The device includes an uptake tube having a proximal end in fluid communication with the first bodily cavity and a distal end in fluid communication with a pump, and an outflow tube having a proximal end in fluid communication with the pump and a distal end in fluid communication with the second bodily cavity. The distal end of the uptake tube may be coupled to a reservoir configured to expand upon ingression of fluid into the reservoir and to contract upon removal of fluid due to a negative pressure provided by the pump. | 09-26-2013 |
20130253410 | Resistive Anti-Obesity Devices - A patient is provided with an increased sense of satiety by increasing resistance to the outflow of food from the stomach and through the intestines. Stomach emptying may be slowed with devices implantable within the gastrointestinal tract below the stomach. Implants are preferably removable and can include artificial strictures that may be adjustable to vary the rate of stomach emptying. Slowing gastric emptying may induce satiety for a longer period and may therefore reduce food consumption. Many of the embodiments include intestinal liners or sleeves, but they need not. The resistor concept may be applied to a simple anchor and resistor without a long liner. | 09-26-2013 |
20130261530 | Adjustable Valve For IOP Control With Reed Valve - A drainage device for implantation in an eye of a patient to treat an ocular condition, that includes an implant body portion comprising of a valve portion. The valve portion may comprise a flexible membrane disposed and arranged in a manner to affect flow of aqueous humor through the implant body portion. The device may also include a reed valve disposed downstream of the flexible membrane. The reed valve may be configured to prevent backflow of aqueous humor toward the membrane and configured to stabilize flow by affecting pressure at the flexible membrane. In one aspect, the reed valve is configured to create backpressure at the membrane that affects the rate of flow at the flexible membrane. | 10-03-2013 |
20130261531 | Arteriovenous Shunt Having a Flow Control Mechanism - An arteriovenous shunt assembly including a shunt and a pull wire operated flow control mechanism. The shunt has a tubular body that defines a fluid passageway between a first end and a second end thereof The pull wire mechanism includes a portion disposed around the tubular shunt in at least one loop. The at least one loop may be selectively tightened or loosened remotely from the shunt to regulate the rate of blood flow through the tubular shunt. | 10-03-2013 |
20130267887 | AQUEOUS HUMOR MICRO-BYPASS SHUNTS - A small shunt can be placed within the eye to aid in drainage of aqueous humor from the anterior chamber of the eye to a pocket between the conjunctiva and the sclera to be absorbed, or to secrete through the cornea or the sclera external to the eye for glaucoma or ocular hypertension treatment. This drainage can decrease the pressure of the eye and potentially modify the course of advancing glaucomatous optic neuropathy as it relates to eye pressure. The shunt is formed of a shape memory polymer material and deformed into a smaller form factor to reduce trauma to the eye resulting from the insertion of the shunt through the sclera to the anterior chamber. Once in situ, the shunt deploys in response to body heat or other external stimulus and expands to its original, larger form factor to provide a secure friction fit of the shunt within the scleral tissue and to enlarge the lumen of the shunt to allow for aqueous flow. | 10-10-2013 |
20130274648 | BLOOD FLOW CONTROLLERS AND METHODS - Blood flow restrictors are discussed. In some examples, a blood flow restrictor apparatus is configured to be placed within a destination vessel for an arteriovenous hemodialysis access. In an example, the apparatus includes a tubular portion including a delivery configuration and a deployed configuration. In a further example, a size-limiting portion is configured to constrain a size of the tubular portion in the deployed configuration. The tubular portion, in some examples, includes a first portion including a first size substantially matching an interior size of the destination vessel with the tubular portion in the deployed configuration. In another example, the tubular portion includes a second portion constrained by the size-limiting portion to include a second size smaller than the first size of the tubular portion. | 10-17-2013 |
20130281910 | OCULAR IMPLANT SYSTEM - The invention relates generally to medical devices and methods for reducing the intraocular pressure in an animal eye and, more particularly, to stent type devices for permitting aqueous outflow from the eye's anterior chamber and associated methods thereof for the treatment of glaucoma. Some aspects provide a self-trephining glaucoma stent and methods thereof which advantageously allow for a “one-step” procedure in which the incision and placement of the stent are accomplished by a single device and operation. This desirably allows for a faster, safer, and less expensive surgical procedure. | 10-24-2013 |
20130281911 | ANCHORED NON-PIERCING DUODENAL SLEEVE AND DELIVERY SYSTEMS - An intragastric implant for obesity treatment is disclosed. The device delays digestion by providing a duodenal sleeve, and may also slows gastric emptying by limiting flow through the pyloric sphincter. The implant includes an elongated axially-compressible duodenal sleeve having a non-tissue-piercing anchor on a proximal end sized to lodge within the duodenal bulb. The anchor may have oppositely-directed anchoring flanges to resists migration in both directions. The sleeve may also have barbed ribs to resist proximal movement back up into the stomach. A method of implant includes collapsing/compressing the device and transorally advancing it through the esophagus to be deployed within the duodenum. A dissolvable jacket may constrain the implant for delivery and naturally dissolve upon implant. Removal of the implant may occur in the reverse. | 10-24-2013 |
20130296764 | SATIATION DEVICES AND METHODS - A device for inducing weight loss in a patient includes a tubular prosthesis self-expandable from a collapsed position in which the prosthesis has a first diameter to an expanded position in which the prosthesis has a second, larger, diameter. In a method for inducing weight loss, the prosthesis is placed in the collapsed position and inserted into a stomach of a patient. The prosthesis is allowed to self-expand from the collapsed position to the expanded position and into contact with the walls of the stomach, where it induces feelings of satiety and/or inhibits modulation of satiety-controlling factors such as Ghrelin. | 11-07-2013 |
20130296765 | INTRAGASTRIC IMPLANTS WITH DUODENAL ANCHORS - Intragastric fluid transfer devices and related methods for operation thereof are disclosed. The intragastric fluid transfer devices and related methods are intended to assist a patient in maintaining a healthy body weight by stimulating the inner stomach walls and/or the inner duodenum walls. Features of the intragastric fluid transfer device include insertion of the devices transorally and without invasive surgery, without associated patient risks of invasive surgery, and without substantial patient discomfort. The life span of these intragastric fluid transfer devices may be material-dependent upon long-term survivability within an acidic stomach, but is intended to last one year or longer. | 11-07-2013 |
20130303969 | SHEATH SYSTEM FOR CATHETER PUMP - A catheter pump assembly is provided that includes an elongate polymeric catheter body, a cannula, and a tubular interface. The elongate polymeric catheter body has a proximal end and a distal end. The cannula has an expandable portion disposed distally of the elongate polymeric catheter body. The cannula can also have another tubular portion that is proximal to the distal portion. The tubular interface has an outer surface configured to be joined to the tubular portion of the cannula and an inner surface. The inner surface is disposed over the distal end of the elongate polymeric catheter body. The tubular interface has a plurality of transverse channels extending outward from the inner surface of the tubular interface. An outer surface of the elongate polymeric catheter body projects into the transverse channels to mechanically integrate the elongate polymeric catheter body with the tubular interface. | 11-14-2013 |
20130303970 | DISTAL BEARING SUPPORT - In various embodiments, a catheter pump is disclosed herein. The catheter pump can include an elongated catheter body having a distal portion including an expandable cannula having an inlet and an outlet. The expandable cannula can have a delivery profile and an operational profile larger than the delivery profile. An impeller assembly can include an impeller shaft, and an impeller body can include one or more blades. The impeller blades can draw blood into the cannula when rotated. Further, an expandable support can have a mounting portion disposed on the impeller shaft distal of the impeller body and a cannula contact portion for reducing a change in tip gap due to bending of the cannula. The cannula contact portion can be disposed distal of the mounting portion. | 11-14-2013 |
20130303971 | CATHETER AND SHUNT SYSTEM INCLUDING THE CATHETER - In one embodiment of the invention a catheter ( | 11-14-2013 |
20130310727 | SATIATION DEVICES AND METHODS - A device for inducing weight loss in a patient includes a tubular prosthesis self-expandable from a collapsed position in which the prosthesis has a first diameter to an expanded position in which the prosthesis has a second, larger, diameter. In a method for inducing weight loss, the prosthesis is placed in the collapsed position and inserted into a stomach of a patient. The prosthesis is allowed to self-expand from the collapsed position to the expanded position and into contact with the walls of the stomach, where it induces feelings of satiety and/or inhibits modulation of satiety-controlling factors such as Ghrelin. | 11-21-2013 |
20130317412 | Flow Control For Treating A Medical Condition - An apparatus for treatment of a medical condition of a patient to provide drainage from a region of a patient to a drainage location includes a memory having a plurality of different selectable treatment algorithms stored therein for treating a medical condition, and may include a processor associated with the memory and configured to execute one of the different treatment algorithms. It also may include a flow system controllable by the processor to regulate drainage of fluid from a body portion having a medical condition, the flow system being controllable according to a selected algorithm of said different selectable treatment algorithms. In one aspect, the apparatus further comprises an implantable medical device for treating an ocular condition, and the processor is carried on the implantable medical device. | 11-28-2013 |
20130317413 | Pre-Biased Membrane Valve - A method of manufacturing a valve for a fluid system is described herein. The method comprises determining a target cracking pressure for the valve of the fluid system, providing an inner wall having a first height and an outer wall having a second height, the first height varying from the second height by a height differential, and attaching a flexible membrane to the outer wall at the second height, wherein a central zone of the flexible membrane is in contact with the inner wall at the first height and the inner wall biases the flexible membrane from a neutral condition. The height differential is selected to provide resistance to displacement from the inner wall until pressure acting on the membrane exceeds the target cracking pressure. | 11-28-2013 |
20130317414 | Devices And Methods For Altering Eating Behaviour - A device for modifying an eating behavior of a subject is provided. The device includes a device body which is attachable to GI tract tissue of a subject and functions in altering an eating behavior thereof. | 11-28-2013 |
20130324908 | NASOLACRIMAL PLUGS - A plug for use in a passage or conduit of a human body is provided. The plug includes a plug body with a first end and a second end. The plug body has a protrusion on an exterior wall. The plug also includes an attaching member at the first end to attach the plug to the passage or conduit. The plug further includes an axial retention tube within the plug body. The plug further includes a reservoir. The reservoir connects to the retention tube at a third end thereof. The reservoir and the retention tube are configured to regulate the flow of fluid in the passage or conduit. | 12-05-2013 |
20130331762 | SYSTEMS, DEVICES, AND METHODS FOR ORGAN RETROPERFUSION ALONG WITH REGIONAL MILD HYPOTHERMIA - Systems, devices, and methods for organ retroperfusion along with regional mild hypothermia. In at least one embodiment of a method of organ perfusion of the present disclosure, the method comprises the steps of positioning at least part of a first catheter having a cannula within an artery of a patient, the first catheter configured to permit arterial blood to flow therethrough and further configured to permit a portion of the arterial blood to flow through the cannula, positioning at least part of a second catheter within a vein of the patient at or near a target organ, the second catheter configured to receive some or all of the portion of the arterial blood, connecting the cannula of the first catheter to a portion of the second catheter so that some or all of the portion of the arterial blood flowing through the cannula is provided into the vein to treat a condition or disease of the target organ, and reducing and/or regulating a temperature of blood flowing through the cannula using a regional hypothermia system operably coupled to the cannula. | 12-12-2013 |
20130338564 | GLAUCOMA DRAINAGE DEVICES INCLUDING VARIO-STABLE VALVES AND ASSOCIATED SYSTEMS AND METHODS - Glaucoma drainage devices including vario-stable valves and associated systems and methods are disclosed. A glaucoma drainage device includes a drainage lumen and a valve system coupled to the drainage lumen to control the flow of fluid through the drainage lumen. The valve system includes an adjustable valve with a diaphragm that is in communication with the drainage lumen and is movable to occupy varying amounts of the drainage lumen. In some embodiments, the valve system is maintained in a desired position without the use of power such that power is only needed when changing a position of the adjustable valve. | 12-19-2013 |
20130338565 | IMPLANTABLE FLUID MANAGEMENT SYSTEM FOR THE REMOVAL OF EXCESS FLUID - An implantable fluid management device, designed to drain excess fluid from a variety of locations in a living host into a second location within the host, such as the bladder of that host. The device may be used to treat ascites, chronic pericardial effusions, normopressure hydrocephalus, hydrocephalus, pulmonary edema, or any fluid collection within the body of a human, or a non-human mammal. | 12-19-2013 |
20130338566 | IMPLANTABLE FLUID MANAGEMENT SYSTEM FOR THE REMOVAL OF EXCESS FLUID - An implantable fluid management device, designed to drain excess fluid from a variety of locations in a living host into a second location within the host, such as the bladder of that host. The device may be used to treat ascites, chronic pericardial effusions, normopressure hydrocephalus, hydrocephalus, pulmonary edema, or any fluid collection within the body of a human, or a non-human mammal. | 12-19-2013 |
20140005587 | Reduction of Gas Escape in Membrane Actuators | 01-02-2014 |
20140005588 | ELECTRICALLY OPERABLE, IN ONE POSSIBLE EMBODIMENT PROGRAMMABLE HYDROCEPHALUS VALVE | 01-02-2014 |
20140005589 | CEREBROSPINAL FLUID EVALUATION SYSTEM HAVING THERMAL FLOW AND FLOW RATE MEASUREMENT PAD USING A PLURALITY OF CONTROL SENSORS | 01-02-2014 |
20140012180 | PERITONEAL DRAIN AND INFUSION - A method to remove ascites from a mammalian body including: draining ascites from the peritoneal cavity to the bladder of the mammalian body, and evacuating the drained ascites out of the bladder. The method may be practiced with a valved fistula implanted into the bladder to form a passage between the peritoneal cavity and the bladder. | 01-09-2014 |
20140012181 | Devices and Methods of Treating Or Ameliorating Diastolic Heart Failure through Pulmonary Valve Intervention - The present teachings provide a device and methods of making and use thereof. Specifically, one aspect of the present teachings provides a device for restricting blood flow entering the lung after each right bean systole. Certain embodiments of the present teachings provide a device that prevents a complete closure of the pulmonary valve leaflets so that a certain amount of blood is allowed to flow from the pulmonary artery to the right ventricle at the end of a right ventricle systole. Other embodiments of the present teachings provide a device that restricts the amount of blood outflowing from the right ventricle to the pulmonary artery. In addition, the present teachings also provide a delivery system for implanting such a device approximately to or at the pulmonary valve. | 01-09-2014 |
20140018722 | APPARATUS AND METHOD FOR CREATING A LUMEN OF A DESIRED SHAPE AND SIZE IN A HOLLOW VISCUS ORGAN FROM TISSUE OF THE ORGAN - An apparatus is positioned in a hollow viscus organ and functions as a template for creating a lumen of a desired shape and size in the organ from the tissue of the organ. The apparatus is comprised of an elongate, flexible tube having opposite proximal and distal ends. The tube has several lumens or pathways that extend through the interior of the tube between the proximal and distal ends of the tube. A directional, steerable feature extends through one of the lumens of the tube. An anchor feature is provided at the tube distal end and is manually operable from the tube proximal end. An exterior surface dimension adjustable feature is provided adjacent the tube distal end. A suction communication feature is provided along at least a portion of | 01-16-2014 |
20140024994 | SINGLE LUMEN DISTAL PERFUSION SHEATH - A distal perfusion sheath (DPS) is provided for cases where blood perfusion is needed for downstream arteries (distal) to the insertion point of the DPS within the target artery. The ability to provide distal perfusion with the DPS allows the DPS to be positioned in the target artery for long periods without causing lack of blood flow (ischemia) to an extremity that the target artery supplies. In certain embodiments, the DPS can still be used for surgical arterial access while allowing blood flow downstream. In addition, embodiments of the DPS configured with longer perfusion shunts can allow a contra-lateral extremity downstream to a large DPS to have blood flow while the sheath is in place. | 01-23-2014 |
20140039374 | Clog Detection in a Flow Control System - Disclosed herein are an apparatus, a system, and a method to monitor drainage from a first region of a patient to a second region. The apparatus comprises pressure sensors configured to measure the pressures of the first and second regions, a flow system to regulate drainage of fluid from the first region to the second region, a memory having a stored pressure drop across the flow system; and a processor associated with the memory and configured to compare the first pressure, the second pressure, and the stored pressure drop threshold and selectively generate control signals based on the comparisons. In some instances, the apparatus further comprises an alarm, and the processor is configured to generate the control signals that trip the alarm when a pressure drop exceeds the stored pressure drop threshold. | 02-06-2014 |
20140039375 | SYSTEMS FOR IMPLANTING AND USING A CONDUIT WITHIN A TISSUE WALL - Various embodiments of the present invention provide a conduit system including an outer lumen ( | 02-06-2014 |
20140052045 | FLOW CONTROL DEVICE - A device for diverting fluid from the ventricles of the brain to another area of the body includes an inlet, an outlet, and a resistance member operatively connected to the inlet and the outlet. The resistance member includes a first plate, a surface of which has a groove which defines a resistance flow channel, an entry of the flow channel being in fluid communication with the inlet and an exit of the flow channel being in fluid communication with the outlet; and a second plate, the second plate being held in abutment with the grooved surface of the first plate so as to define a resistance tube. The resistance tube includes a plurality of arcs arranged in flow series, each arc radially extending between the inner and outer diameters of the first and second plates. A selection mechanism operable to interconnect a selected number of the arcs to the inlet and outlet is provided. | 02-20-2014 |
20140052046 | REDUCTION OF INTRAOCULAR PRESSURE IN THE EYE USING A TUBULAR CLIP - Drainage of aqueous from the anterior chamber of the eye can be facilitated by a malleable hollow clip or staple that can be formed to attach to ophthalmic tissue and provide intra-luminal flow of aqueous through the clip. In addition, the clip can be adjusted to modulate the outflow rate of aqueous, both during the initial surgical procedure as well as on a post-procedure basis. Furthermore, an instrument is described in which the forceps of the clip delivery device reside inside the lumen of hollow clip during deployment and manipulation. Features of an instrument are designed to secure the clip to the delivery forceps and prevent tissue blockage of the clip lumens. The clips may be color-matched to the underlying tissue for the purpose of camouflage and may carry pharmaceuticals. | 02-20-2014 |
20140052047 | METHOD AND TOOLS FOR IMPLANTED DEVICE - A method and toolset capable of remotely moving a rotor of an implanted device in a first arcuate direction and detecting a first limit of travel, moving the rotor in a second, opposite direction and detecting a second limit of travel without altering the current performance setting of the implanted device, comparing the first and second limits of travel with known values for a plurality of selectable performance settings, and indicating the current performance setting of the implanted device. | 02-20-2014 |
20140066832 | Capillary Valve - A capillary fluid flow valve may include a chamber having a first boundary surface and a second boundary surface defined by a housing. The first and second boundary surfaces may be spaced apart by a gap sized to invoke capillary action between the surfaces. The first surface may be angled relative to the second surface. The chamber may have an inlet port, an outlet port, and an air vent port. The gap at the air vent port may be smaller than the gap at the outlet port and the gap at the outlet port may be smaller than the gap at the inlet port. | 03-06-2014 |
20140066833 | EXPANDABLE FLUID DRAINAGE IMPLANTS AND ASSOCIATED DELIVERY DEVICES AND METHODS - A drainage implant is provided for the drainage of aqueous humor. The implant may comprise a collector, a connector and disperser. The collector and/or disperser may be self-expandable and can be held in an unexpanded condition by a delivery device. When positioned for implantation, the collector and disperser are ejected from the delivery device, whereby upon being ejected from the delivery device they can expand to a pre-defined final shape in the desired place. A delivery device for implanting the implant may have a shaft for accommodating the implant and a cutting edge that may be used to create a pocket or reservoir in the tissue where the implant device is to be implanted. Methods of implanting an implant are also disclosed. | 03-06-2014 |
20140081196 | FLOW CONTROL DEVICE, SYSTEM AND METHOD FOR CONTROLLING THE FLOW OF BODY FLUID - Disclosed herein is a device for controlling the flow of a body fluid from a first tissue/organ to a second tissue/organ of a subject. The flow control device includes a main body, a first fluid channel, a second fluid channel, a detection member, and a control member. The main body defines a lumen for accommodating the body fluid flowing from the first tissue/organ into the lumen. The first fluid channel is in fluid communication with the lumen and the first tissue/organ; while the second fluid channel is in fluid communication with the lumen and the second tissue/organ. The detection member is in fluid communication with the lumen, and is operable to detect at least one parameter associated with the flow of the body fluid. The control member is operable to control the flow of the body fluid from the first tissue/organ to the second tissue/organ of the subject. | 03-20-2014 |
20140094735 | VALVE SYSTEM AND METHOD WITH MULTI-DIRECTIONAL PUMPING - An implantable valve system and method of using same, including a housing with a resilient membrane defining a reservoir in fluid communication with at least two ports, and at least a first set of opposing sealing features disposed on upper and lower surfaces within the housing. The membrane is capable of being depressed by a human finger to bring the sealing features together to substantially restrict fluid from passing through at least one of one of the ports, and is capable of being depressed additionally by a rolling motion of the finger to drive fluid through the other of the ports. | 04-03-2014 |
20140094736 | Valve Position Sensor - An IOP control device for implantation in an eye of a patient is disclosed, including a housing with an entrance port and an exit port, a membrane anchored within the housing in a manner forming a flow control chamber on a first side of the membrane and a fluid flow passageway on a second opposing side of the membrane, and a position sensor system. The flow control chamber is arranged to contain a gas creating a flow control chamber pressure, and the membrane is configured to affect flow through the fluid flow passageway from the entrance port to the exit port by deflecting in response to changes in the flow control chamber pressure. The position sensor system includes a first conductive portion and a second conductive portion positioned to selectively contact the first conductive portion to indicate the position of the membrane relative to the fluid flow passageway. | 04-03-2014 |
20140100513 | METHOD AND APPARATUS FOR REDUCING OBESITY - Method and apparatus for treatment of morbid obesity by placement of a series of flow reduction elements in the small intestine to induce satiety are disclosed. The flow reduction elements restrict the movement of partially digested food and reduce the flow rate through the small intestine which causes the emptying of the stomach and the duodenum to occur slower. The flow reduction elements are attached to an elongated tube and are constructed from various shapes and configurations. The flow reduction elements may be inflated with fluid or may be constructed from self-expandable materials. The device is anchored in the antrum of the stomach with an anchoring member. The transoral gastric device can be inserted with a delivery catheter through the working lumen of an endoscope or alongside an endoscope and may be removed with the aid of an endoscope if desired. | 04-10-2014 |
20140107557 | CAPILLARY ACTION IN FLOW-REGULATING SYSTEMS - A fluid flow-regulating system includes an electrolysis chamber configured to contain a liquid, and includes first and second electrodes disposed within the electrolysis chamber. A gap between opposing surfaces is sized to promote capillary action of a liquid in the electrolysis chamber that draws the liquid to at least one of the first and second electrodes in a manner allowing the flow-regulating system to be placed in multiple orientations and still have said one of the first and second electrodes wetted by capillary action. | 04-17-2014 |
20140121585 | INTRALUMINAL DEVICE AND METHOD WITH ENHANCED ANTI-MIGRATION - An intraluminal device and method includes positioning the intraluminal device, such as a bariatric device, in a lumen that is subject to peristaltic waves, such as the GI tract. The intraluminal device includes a surface defined by a wall having opposite end portions. The surface is configured to generally conform to the shape and size of a portion of the lumen. The end portions are spaced apart along an axis in the direction of peristaltic movement along the lumen. The cover has at least one opening therein between the end portions in order to resist peristaltic waves causing distal migration of the device. | 05-01-2014 |
20140121586 | Tool For Adjusting An Implantable Adjustable Fluid Flow Control Valve - Tools for determining and adjusting the setting of an adjustable valve are disclosed. These tools allow a medical professional to locate and non-invasively determine the setting of an implanted valve. After the valve has been located and the setting of the valve determined, the valve may be re-adjusted non-invasively. There are three tools: a locator tool, an indicator tool and an adjustment tool. The locator tool allows the physician to locate the adjustable valve of interest and align the locator tool with a specific orientation of the valve. The indicator tool indicates the current setting of the adjustable valve and confirms new settings of the valve after the new settings have been implemented. The adjustment tool interacts magnetically with the implanted adjustable valve to couple with a movable internal element to change the setting of the valve. The indicator tool and the adjustment tool physically cooperate with the locator tool to accomplish the respective functions of the tools. | 05-01-2014 |
20140128793 | SYSTEM AND METHOD FOR PYELOPLASTY INTERNAL-EXTERNAL STENT - A system and method is provided for the deployment of a ureter between a kidney and a bladder. A stent includes a flexible internal drainage portion, a retention portion, and an external drainage portion. The external drainage portion includes a sharpened tip configured to be passed from through a renal pelvis and out the side of a patient's body from inside the ureter. The stent is arranged to be removable by pulling the external drainage portion and thereby removing the stent out the side of the body. | 05-08-2014 |
20140128794 | DIALYSIS VALVE AND METHOD - A dialysis valve includes a tube attached between an artery and a vein which, when elongated, simultaneously narrows in diameter at at least one location. The narrowed portion of the tube decreases the volume and velocity between the arterial and venous side of the patient to prevent damage or intimal hyperplasia on the venous side between dialysis treatments. When the valve is opened for dialysis, an unrestricted blood flow exists between the arterial and venous side, permitting a controlled, open blood flow during dialysis. | 05-08-2014 |
20140128795 | METHODS AND APPARATUS FOR REDUCING LOCALIZED CIRCULATORY SYSTEM PRESSURE - The present invention is thus directed to methods and apparatus for decreasing pressure in a first portion of a vessel of the cardiac structure of a patient by implanting a shunt communicating with an area outside said first portion, whereby a volume of blood sufficient to reduce pressure in said first portion is released. | 05-08-2014 |
20140128796 | METHODS AND APPARATUS FOR REDUCING LOCALIZED CIRCULATORY SYSTEM PRESSURE - The present invention is thus directed to methods and apparatus for decreasing pressure in a first portion of a vessel of the cardiac structure of a patient by implanting a shunt communicating with an area outside said first portion, whereby a volume of blood sufficient to reduce pressure in said first portion is released. | 05-08-2014 |
20140148752 | A DEVICE FOR ADJUSTING THE INTRAOCULAR PRESSURE - Provided is a device for use in controlling the liquid outflow from the anterior chamber of the eye, methods of draining aqueous humor from the anterior chamber to the intra-orbital space using the device, methods for controlling the liquid outflow from the anterior chamber of the eye and further surgical methods for implanting the presently described device. | 05-29-2014 |
20140155806 | DEVICE FOR DRAINING LYMPH INTO VEIN - The present invention relates to a device for draining lymph into vein, which comprises: a storage chamber including a chamber wall, wherein a storage space formed by the chamber wall, and at least one first opening and a second opening are formed on the chamber wall; at least one osmosis membrane disposed at the first opening so that lymph can penetrate into the storage space, wherein the osmosis membrane is made of negative charged polymer molecules; a first conduit, of which one end connects to the storage space, and the other end connects with a vein so that the space can connect with the vein; and a pump provided in the storage chamber, wherein a negative pressure in the storage space is generated by the pump to drain lymph into the vein. | 06-05-2014 |
20140155807 | INTESTINAL BRAKE INDUCING INTRALUMINAL THERAPEUTIC SUBSTANCE ELUTING DEVICES AND METHODS - Methods and devices create an intestinal braking effect, are non-invasive or minimally invasive, and may be reversible. These methods and devices are accomplished via stabilized implantable systems, and ingestible pills. In one embodiment, the implantable system comprises a device delivering a therapeutic substance to a target location within the gastrointestinal tract of a patient in order to initiate an intestinal braking effect which would promote sensations of satiety and stimulate excess weight loss for the patient. | 06-05-2014 |
20140163448 | SUPRACHORIODAL DRAINAGE TUBE IN A FLOW CONTROL SYSTEM - Described herein is a treatment device for the drainage of fluid within an eye of a patient. The treatment device comprises a drainage tube and a flow system in fluid communication with the drainage tube. The drainage tube has a lumen and comprises an inlet tube portion and an outlet tube portion, and is configured to convey aqueous humor through the lumen from an anterior chamber of the eye to a suprachoroidal space of the eye. The inlet tube portion extends from the anterior chamber to the flow system, and the outlet tube portion is flexible to conform to the curvature of the suprachoroidal space and extends from the valve system to the suprachoroidal space. The flow system is configured to control intraocular pressure by throttling flow rates of the aqueous humor through the drainage tube. | 06-12-2014 |
20140163449 | DEVICE AND METHOD FOR CONTROLLING IN-VIVO PRESSURE - A differential pressure regulating device is provided for controlling in-vivo pressure in a body, and in particularly in a heart. The device may include a shunt being positioned between two or more lumens in a body, to enable fluids to flow between the lumens, and an adjustable flow regulation mechanism being configured to selectively cover an opening of the shunt, to regulate the flow of fluid through the shunt in relation to a pressure difference between the body lumens. In some embodiments a control mechanism coupled to the adjustable flow regulation mechanism may be provided, to remotely activate the adjustable flow regulation mechanism. | 06-12-2014 |
20140188032 | CEREBROSPINAL FLUID DRAINAGE - A cerebrospinal fluid drainage. The abstract of the disclosure is submitted herewith as required by 37 C.F.R. §1.72(b). As stated in 37 C.F.R. §1.72(b): A brief abstract of the technical disclosure in the specification must commence on a separate sheet, preferably following the claims, under the heading “Abstract of the Disclosure.” The purpose of the abstract is to enable the Patent and Trademark Office and the public generally to determine quickly from a cursory inspection the nature and gist of the technical disclosure. The abstract shall not be used for interpreting the scope of the claims. Therefore, any statements made relating to the abstract are not intended to limit the claims in any manner and should not be interpreted as limiting the claims in any manner. | 07-03-2014 |
20140207045 | SYSTEMS AND METHODS FOR SHUNTING FLUID - Systems and methods are provided herein that generally involve shunting fluid, e.g., shunting cerebrospinal fluid in the treatment of hydrocephalus. Self-cleaning catheters are provided which include split tips configured such that pulsatile flow of fluid in a cavity in which the catheter is inserted can cause the tips to strike one another and thereby clear obstructions. Catheters with built-in flow indicators are also provided. Exemplary flow indicators include projections that extend radially inward from the interior surface of the catheter and which include imageable portions (e.g., portions which are visible under magnetic resonance imaging (MRI)). Movement of the flow indicators caused by fluid flowing through the catheter can be detected using MRI, thereby providing a reliable indication as to whether the catheter is partially or completely blocked. Systems and methods for flushing a shunt system are also disclosed herein, as are various systems and methods for opening auxiliary fluid pathways through a shunt system. | 07-24-2014 |
20140213959 | DEVICE AND METHOD FOR REGULATING PRESSURE IN A HEART CHAMBER - A device for regulating blood pressure in a heart chamber is provided. The device includes a shunt positionable within a septum of the heart. The shunt is designed for enabling blood flow between a left heart chamber and a right heart chamber, wherein the flow rate capacity of the device is mostly a function of pressure in the left heart chamber. | 07-31-2014 |
20140213960 | GASTROINTESTINAL PROSTHESES - A system for therapy within a gastrointestinal system includes anchoring or attachment functionality embodied in a low-profile implant technology and removable therapy components, which can be reversibly attached to these low-profile implants to accomplish various therapies. This design allows the physician to tailor the therapy to the patient's needs. The system has the potential to create conduits for diversion and/or restriction of food and organ secretions and to facilitate the treatment of metabolic disorders such as obesity and T2DM. | 07-31-2014 |
20140236066 | ADJUSTABLE INTRAOCULAR FLOW REGULATION - Methods and devices for adjusting or configuring the flow rate of an intraocular shunt are provided whereby hypotony can be avoided by increasing the flow rate through the device. In some embodiments, the device is a shunt that can have a first flow that can be modified to a second flow by modifying the shunt, such as by cutting the shunt. Additionally, one or more dissolvable portions can be present to provide an initial flow restriction and subsequent increase in flow over time. | 08-21-2014 |
20140236067 | ADJUSTABLE GLAUCOMA IMPLANT - Methods and devices for adjusting or configuring the flow rate of an intraocular shunt are provided whereby hypotony can be avoided by increasing the flow rate through the device. In some embodiments, the device is a shunt that can have a first flow that can be modified to a second flow by modifying the shunt, such as by cutting the shunt. Additionally, one or more dissolvable portions can be present to provide an initial flow restriction and subsequent increase in flow over time. | 08-21-2014 |
20140236068 | GLAUCOMA SHUNTS WITH FLOW MANAGEMENT AND IMPROVED SURGICAL PERFORMANCE - A method of treating glaucoma in an eye by managing fluid flow past an implanted shunt having an elastomeric plate and a non-valved elastomeric drainage tube. The plate is positioned over a sclera of the eye with an outflow end of the elastomeric drainage tube open to an outer face of the plate. An inflow end of the drainage tube tunnels through the sclera and cornea to the anterior chamber of the eye. The plate may have regions of greater propensity for cell adhesion alternating with regions of lesser cell adhesion. For example, regions of texturing around the plate or drainage tube may be provided to control the size of a bleb that forms over the implant. The effective surface area of the plate may be balanced against a number of fenestrations. The drainage tube has a reduced profile and may be shaped with a non-circular external cross-section to reduce its height. A scleral groove may be used to further reduce the height of the drainage tube on the sclera. A flow restrictor for the early post operative period will immediately lower the intraocular pressure (IOP). | 08-21-2014 |
20140243731 | INTRAOCULAR PRESSURE SENSOR WITH EXTERNAL PRESSURE COMPENSATION - An intraocular pressure sensor system has a first pressure sensor located in an anterior chamber of an eye and a remote pressure sensor located remotely from the first pressure sensor. The remote pressure sensor measures or approximates atmospheric pressure. A difference between readings from the first pressure sensor and the remote pressure sensor approximates intraocular pressure. | 08-28-2014 |
20140249465 | METHODS FOR RETAINING A GASTRO-ESOPHAGEAL IMPLANT - Various methods and devices are described for retaining a medical implant within a body cavity. According to one aspect, at least a portion of a medical implant is positioned within a body cavity, and a wall of the body cavity is re-shaped such that the re-shaped wall prevents migration of the medical implant out of the body cavity. The re-shaped body wall may form a tissue pocket, tunnel, or other barrier against migration of the implant. | 09-04-2014 |
20140257166 | Transcutaneous telemetry of cerebrospinal fluid shunt programmable-valve pressure using near-infrared (NIR) light - An improvement for a programmable valve system of the type implanted in a patient and used to divert cerebrospinal fluid (CSF) from an intraventricular space to a terminus such as the peritoneal cavity. Such system includes means for establishing a flow path for the CSF to the terminus, which flow path includes a normally closed valve and means for adjusting the opening pressure of the valve in order to regulate the quantity of CSF diverted. The improvement enables an operator to be apprised of the actual opening pressure setting of the valve. A sensor is implantable at the patient and responds to the actual opening pressure setting, by generating an NIR telemetry signal indicative of the actual setting. This signal is transcutaneously transmitted through the skin of the patient to an external point. The telemetry signal is processed to produce observer intelligible data indicating the opening pressure setting of the valve. | 09-11-2014 |
20140257167 | DEVICES AND METHODS FOR THE TREATMENT OF HEART FAILURE - A device for treating a heart condition in a patient. The device has a body adapted and configured to self-expand from a radially collapsed configuration to an expanded configuration. In its expanded configuration, the device has a first section at a first end, a second section at a second end and a central portion extending between the first and second sections, the first and second sections each having diameters that increase with distance from the central portion toward the first and second ends, respectively. The body is configured to be delivered percutaneously to a patient's heart and allowed to self-expand in an opening in a septum of the heart to dispose the first end in the left atrium, the second end in the right atrium and the central portion in the opening to permit blood to flow through the body from the left atrium to the right atrium. | 09-11-2014 |
20140257168 | NEUROSURGICAL APPARATUS - A cerebral catheter device for draining fluid from the brain of a patient is described. The device may be used as part of a ventricular shunt system. The device includes an elongate tube for insertion into the brain of a patient to a vicinity of a desired target. A head is attached to the elongate tube that has a passageway in fluid communication with a lumen of the elongate tube. Formations are provided on the external surface of the head for securing the head in a hole formed in the skull of a patient. The head further includes a first fluid connector portion that is attachable to an associated drainage catheter device. This allows fluid communication to be established between the lumen of the elongate tube and a drainage catheter device via the passageway of the head. | 09-11-2014 |
20140276339 | DYNAMIC ADJUSTMENT TOOL FOR PROGRAMMING AN IMPLANTABLE VALVE - A tool includes a locator having a center aligned with a rotor axis when disposed over the valve. The locator has a first dimension approximately perpendicular with the rotor axis. A wall of the locator forms a volume to allow an adjustor to be disposed therein. The adjustor fits within the wall and has a magnet having a magnetic axis to unlock the rotor. An adjustable outer wall has a first position dimension permitting the adjustor to rotate about the center of the locator and aligning the magnetic axis with the center. The adjustable outer wall has a second position dimension less than the first dimension and the first position dimension. The adjustor can move lateral, rotational, and orbital in the locator misaligning the magnetic axis with the center. Misaligning the magnetic and rotor axes unlocks the rotors and the magnet maintains the unlocked state even when the axes are misaligned. | 09-18-2014 |
20140276340 | SYSTEM AND METHOD FOR DETERMINING POSITION AND PRESSURE OF AN IMPLANTABLE SHUNT - In one aspect, an implantable shunt system is disclosed that, in one example implementation, includes a resilient member and a connected fluid regulating device. The fluid regulating device selectively permits fluid flow through an opening valve of an implantable shunt according to an adjustable opening pressure. The opening pressure is proportional to an amount of tension on the resilient member. One or more tension sensors that are connected to the resilient member measure an amount of tension on the resilient member. The tension sensors generate tension data that corresponds to the measured amount of tension. The system further includes a communication unit with a transmitting unit that transmits the measured data over a communication link. | 09-18-2014 |
20140276341 | DETECTION AND CLEARING OF OCCLUSIONS IN CATHETERS - A catheter system with integral sensing and clearing of occlusions is described. The system can include a catheter in fluid communication with a shunt for transporting a bodily fluid within, or out of, a patient's body. The catheter and/or the shunt can include one or more detection wires and one or more transmission wires. The detection wires can be in electrical communication with the fluid and can enable the detection of changes in electrical properties of the fluid indicating an occlusion, or other anomaly, in the catheter. The transmission wires can be in electrical communication with the fluid and can enable the application of electromagnetic energy to the occlusion to facilitate its removal. The detection wires and the transmission wires can be the same or different wires. The system can include a probe that can be externally connected to the wires to provide detection and or transmission signals. | 09-18-2014 |
20140276342 | DEVICES, SYSTEMS AND METHODS FOR DIVERTING FLUID TRAPPED IN A SOLID ORGAN - The invention provides devices with specialized ends for diverting fluids trapped in an organ. In a first group of embodiments, the invention provides implantable devices that shunt fluid trapped in a patient's organ to its normal physiological destination. In a second group of embodiments, the invention provides devices with specialized ends for connecting the devices to conventional medical tubing to divert fluid trapped in an organ to a destination selected by the practitioner. The invention further provides systems and methods of using the devices. | 09-18-2014 |
20140276343 | ACOUSTIC STREAMING GLAUCOMA DRAINAGE DEVICE - An acoustic streaming valve arrangement induces flow in a glaucoma drainage device. The arrangement may include a selectively vibrating flow generator having a sharp edge and a driving device configured to selectively vibrate the flow generator to create a streaming fluid flow in a direction away from the sharp edge. | 09-18-2014 |
20140276344 | SHUNTING OF DIETARY LIPIDS INCLUDING CHOLESTEROL - Methods and devices for redirecting at least a portion of a fluid from the mesenteric lymphatic system for elimination from the body are disclosed. The fluid may be redirected for elimination through the urinary system or redirected outside the body. The methods and devices disclosed may prevent a portion of a patient's dietary lipids, including cholesterol, from being absorbed, thereby reducing the total caloric load to assist in weight management. | 09-18-2014 |
20140276345 | VALVE, IMPLANT INCLUDING THE VALVE, FLUID TRANSFER ARRANGEMENT, AND METHOD OF TREATMENT USING THE SAME - A valve includes a housing with a cavity having at least one connector fluidically connecting the cavity to an outside of the housing and a plug that is movable within the housing. The plug is movable at least between a first position that substantially occludes fluidic communication between the cavity and an outside of the housing through the at least one connector and a second position that allows fluidic communication between the cavity and the outside of the housing through the at least one connector. The valve also includes a septum in operable communication with the housing that is sealingly penetrable by a fluid transfer device, wherein the fluid transfer device is capable of moving the plug between at least the first position and the second position. | 09-18-2014 |
20140276346 | SHUNT FLOW MONITOR - A shunt including an implantable housing having a proximal end and a distal end. A pressure sensitive valve is contained within the housing at a position between the proximal end and the distal end, and the pressure sensitive valve is capable of controlling a flow of fluid between the fluid inlet port and the fluid outlet port. The shunt further including a sensor assembly fluidly coupled to the pressure sensitive valve, wherein the sensor assembly is mechanically actuated and capable of detecting the flow of fluid through the pressure sensitive valve. A condition of the shunt can be detected by detecting a flow of fluid through the shunt and generating a signal indicative of a period of fluid flow through the implantable shunt based on the detecting. The signal can be output to an external device capable of determining, from the signal, whether the shunt is malfunctioning. | 09-18-2014 |
20140276347 | INTRAOSSEOUS SHUNTS - An intraosseus shunt can comprise a shunt body and a valve. The shunt body can be configured for insertion into bone and can have a fluid inlet, a fluid outlet, and a flow passage extending within the shunt body between the fluid inlet and the fluid outlet. The flow passage, the fluid inlet, and the fluid outlet can be configured for cerebrospinal fluid flow therethrough to cancellous bone. The valve can be attached to the shunt body and configured to control flow through the flow passage. A method of shunting biological fluid away from a hyper-pressurized biological cavity to a bone can comprise (i) creating a passage through cortical bone to provide access to cancellous bone, and (ii) positioning the shunt into the passage. The valve can control communication between the biological cavity and the cancellous bone. | 09-18-2014 |
20140296769 | Methods and Systems for Establishing Retrograde Carotid Arterial Blood Flow - Devices and methods establish and facilitate retrograde or reverse flow blood circulation in the region of the carotid artery bifurcation in order to limit or prevent the release of emboli into the cerebral vasculature such as into the internal carotid artery. The methods are particularly useful for interventional procedures performed through a transcervical approach or transfemoral into the common carotid artery. | 10-02-2014 |
20140296770 | TRANSPYLORIC ANCHORING - Gastrointestinal implants can be used to secure thin-walled sleeves, restrictor plates, and other devices within the gastrointestinal tract. An example implant includes three elements: a stomach anchor to resist distally oriented forces; a duodenal anchor to resist proximally oriented forces; and a connector element to keep the stomach anchor fixed relative to the stomach anchor. The implant is inserted into the gastrointestinal tract with a delivery device that holds the implant in a compressed state for minimally invasive delivery until the implant is positioned properly. Upon releasing from the delivery device, the implant expands to a relaxed state across the pylorus, allowing prongs that extending outward from the stomach and duodenal anchors to engage tissue in the gastrointestinal tract. The deployed implant may also include a thin-walled sleeve that extends into the intestine from the stomach anchor, duodenal anchor, or connector element. | 10-02-2014 |
20140303544 | IMPLANTS WITH CONTROLLED DRUG DELIVERY FEATURES AND METHODS OF USING SAME - Disclosed herein are drug delivery devices and methods for the treatment of ocular disorders requiring targeted and controlled administration of a drug to an interior portion of the eye for reduction or prevention of symptoms of the disorder. The devices are capable of controlled release of one or more drugs and may also include structures which allow for treatment of increased intraocular pressure by permitting aqueous humor to flow out of the anterior chamber of the eye through the device. | 10-09-2014 |
20140309577 | SMART SHUNT DEVICES AND METHODS - Devices and methods for the measurement and control of fluid using one or two capacitors are described. The devices use Micro-Electro-Mechanical-Systems (MEMS) and radio-frequency inductive coupling to sense the properties of a fluid in a tube. The single and double capacitor devices may be coupled to shunts implantable in a patient and operable to be interrogated non-invasively. The shunts employing the novel capacitor devices are insensitive to stray signals such as the orientation of a patient's head. The devices are operable to employ a wireless external spectrometer to measure passive subcutaneous components. | 10-16-2014 |
20140316325 | CSF SHUNT VALVE - The CSF shunt valve includes an elongate, hollow housing and a valve unit disposed within the housing. A plurality of exit ports are formed along the wall of the housing, and a plurality of bleeder ports are formed on the bottom of the housing. The valve unit includes at least one regulating mechanism disposed within the housing. Each regulating mechanism includes an obstructing member operatively attached to a spring. The spring is compressible within a predefined range of fluid pressure. The obstructing member compresses the attached spring in response to fluid pressure acting thereon, opening the exit ports for fluid being drained. The spring-biased obstructing members facilitate self-adjustment for drainage flow. Although arranged in series, the range limits are not continuous with subsequent springs, which safeguards against transient spikes in fluid pressure and ensures independent compression of subsequent springs in response to the predefined limits of pressure for that spring. | 10-23-2014 |
20140336559 | ENDOVASCULAR CEREBROSPINAL FLUID SHUNT - An implantable shunt device for draining cerebrospinal fluid from a patient's subarachnoid space. The device includes a shunt having opposed first and second ends. A one-way valve is located at the first end of the shunt. A helical tip is disposed at the second end. The helical tip is constructed to penetrate a sinus wall of the patient. Upon implantation, a hollow passageway extends between the helical tip and one-way valve such that fluid can be drained through the helical tip and out through the valve. The endovascular cerebrospinal fluid shunt of the present invention can be placed into a patient percutaneously via a catheter inserted into the venous system of the body through a needle hole, without the need for open surgery and the skin incisions required with current shunt devices. The device also allows for more physiologic drainage of cerebrospinal fluid since the device is shunting cerebrospinal fluid into the same cerebral venous system that occurs naturally in normal people. | 11-13-2014 |
20140336560 | EXTERNALLY PROGRAMMABLE VALVE ASSEMBLY - An externally programmable shunt valve assembly that includes a magnetic rotor that is operable in response to an externally applied magnetic field and configured to increase or decrease the working pressure of the shunt valve assembly in finite increments. | 11-13-2014 |
20140343477 | PANCREATIOBILIARY DIVERSION DEVICE - Apparatus ( | 11-20-2014 |
20140371653 | Methods and Systems for Establishing Retrograde Carotid Arterial Blood Flow - Interventional procedures on the carotid arteries are performed through a transcervical access while retrograde blood flow is established from the internal carotid artery to a venous or external location. A system for use in accessing and treating a carotid artery includes an arterial access device, a shunt fluidly connected to the arterial access device, and a flow control assembly coupled to the shunt and adapted to regulate blood flow through the shunt between at least a first blood flow state and at least a second blood flow state. The flow control assembly includes one or more components that interact with the blood flow through the shunt. | 12-18-2014 |
20150011927 | METHODS AND SYSTEMS FOR INTRAVENTRICULAR BRAIN STIMULATION - The present application is directed to devices and methods that can treat dementia or other brain disorders via electrical stimulation. Embodiments disclosed herein utilize brain stimulation of brain areas involved in memory and cognition through an intraventricular approach. Brain stimulation is combined with CSF flow in an intraventricular electrode having one or more passageways to permit fluid to flow therethrough. For example, an intraventricular electrode shunt catheter can be safely placed in any part of the ventricular system and through any foramen or aqueduct of the ventricular system without fear of obstruction to CSF flow. | 01-08-2015 |
20150045716 | INTRAOCULAR PRESSURE COMPENSATING AND REGULATING VALVE - An intraocular pressure compensating and regulating valve installed inside the eye's cornea, comprising: a valve body having a valve seat at an end; a mobile element connected to the valve seat under normal intraocular pressure conditions inside the eye, the mobile element is configured such that it can be separated from the valve seat when the intraocular pressure exceeds the intraocular pressure limit; and an element to keep the mobile element in contact with the valve seat. | 02-12-2015 |
20150045717 | Real Time CSF Flow Measurement System & Method - A system for measuring quantitative CSF flow in shunt tubing implanted under the skin. The system includes an array of thermo-sensors clustered in three sections, cooling device, placed on the skin surface and an associated data acquisition and analysis device. Two sensor sections are placed over the shunt on the skin and measure real time temperature responses related to CSF movement. One array placed adjacent the cooling device collects data on thermal properties of skin including skin thermal conductivity, specific heat, diffusivity, perfusion, and thermal inertia. The method involves assessing thermal properties of skin and measuring CSF flow in shunt tubing. The method is useful for shunt patency assessment, CSF valve adjustment procedures and CSF flow measurements related to CSF over drainage. Alternatively, only one section of sensors need be used when determining relative CSF flow, without the need to determine thermal skin properties and by applying the cooling device continuously. | 02-12-2015 |
20150051533 | SATIATION POUCHES AND METHODS OF USE - A method for controlling appetite by means of a satiation device is disclosed. The device, which includes a flexible webbing defining proximal and distal openings and a biasing structure, is attached to the patient's stomach with the proximal opening positioned adjacent and below the patient's gastro-esophageal junction. The biasing structure imparts pressure against the wall of the patient's stomach adjacent the gastro-esophageal junction. | 02-19-2015 |
20150057592 | MEMS CHECK VALVE CHIP AND METHODS - A MEMS check valve chip is described. The chip comprises a first side and an opposing second side, an outlet port extending from the first side to the second side, and a flexible outlet membrane anchored to the first side to overlie the outlet port. The flexible outlet membrane includes an outlet aperture and a sealing portion, and the sealing portion is movable between a closed position inhibiting fluid flow through the outlet aperture and an open position wherein the sealing portion displaces into the outlet port to permit fluid flow through the outlet aperture. | 02-26-2015 |
20150057593 | SYSTEMS AND METHODS FOR PRIMING A MICROFLUIDIC CHAMBER - An intraocular device for implantation in an eye of a patient is provided. The intraocular device includes an inlet tube, an outlet tube, and a microfluidic chamber. The microfluidic chamber includes a chamber inlet coupled to the inlet tube, a chamber outlet coupled to the outlet tube, and one or more fluidic barriers. Each fluidic barrier is configured such that, as a fluid is injected into the microfluidic chamber, a front of the fluid coincides with the fluidic barrier before any of the fluid passes beyond the fluidic barrier. Associated methods are also disclosed herein. | 02-26-2015 |
20150057594 | BUBBLE-FREE MICROFLUIDIC VALVE SYSTEMS AND METHODS - A microfluidic valve for implantation in an eye of a patient is disclosed. The valve may include a chamber formed between a substrate and a flexible membrane. The valve may also include a boss disposed in the chamber and having a top edge in selective contact with the flexible membrane. The top edge includes a relief portion and a non-relief portion, with the relief portion being structurally arranged so that a pressure required to separate the membrane from the relief portion is less than a pressure required to separate the membrane from the non-relief portion. The valve also may include an inlet extending through the boss and the substrate through which fluid enters the chamber and an outlet configured to allow fluid to exit the chamber. Methods for priming a microfluidic valve are also disclosed. | 02-26-2015 |
20150057595 | PRESSURE-BASED FLOW RATE MEASUREMENT FOR OCULAR IMPLANTS - Described herein is an IOP control device for implantation in an eye of a patient, comprising a drainage tube, a pressure-driven flow system, and a flow rate measurement system. The drainage tube includes a drainage lumen in fluid communication with an anterior chamber of the eye. The flow system is in fluid communication with the drainage lumen, and is configured to control the flow of fluid through the drainage tube. The flow rate measurement system is disposed distal to the flow system, and comprises a flow tube including a known hydraulic resistance to flow, a proximal pressure sensor disposed at the proximal end of the flow tube, and a distal pressure sensor disposed at the distal end of the flow tube. The flow tube includes a proximal end, a distal end, and a lumen extending therebetween that is configured to be in fluid communication with the drainage lumen. | 02-26-2015 |
20150057596 | PASSIVE TO ACTIVE STAGED DRAINAGE DEVICE - Described herein is an IOP control system for implantation in an eye of a patient, comprising a drainage device and a control device. The drainage system includes a housing including an inlet port and an outlet port, a fluid flow passageway extending from the inlet port to the outlet port to allow the flow of fluid therethrough, and at least one valve disposed within the housing. The at least one valve includes a first side and an opposing second side, and is configured to affect flow through the fluid flow passageway from the inlet port to the outlet port by moving in response to pressure differentials acting on the opposing sides. The control device comprises an actuator including an activated mode and a deactivated mode, and the actuator in the activated mode is configured to selectively adjust flow through the drainage device in response to changes in intraocular pressure. | 02-26-2015 |
20150057597 | EXTERNALLY ADJUSTABLE PASSIVE DRAINAGE DEVICE - Described herein is an IOP control device for implantation in an eye of a patient, comprising a housing including an inlet port and an outlet port, a fluid flow passageway configured to allow the flow of fluid from the inlet port to the outlet port, and at least one valve anchored within the housing. The at least one valve includes a first side and an opposing second side, and is configured to affect flow through the fluid flow passageway from the inlet port to the outlet port by moving in response to pressure differentials acting on the opposing first and second sides. The at least one valve is remotely adjustable between an active condition increasing resistance to the flow of fluid within the fluid flow passageway and an inactive condition decreasing resistance to the flow of fluid within the fluid flow passageway. | 02-26-2015 |
20150073329 | SYSTEMS, DEVICES, AND METHODS FOR AUTORETROPERFUSION - Devices, systems, and methods for autoretroperfusion. In at least one embodiment of a perfusion system of the present disclosure, the system comprises a first catheter having a proximal end, a distal end, and a first lumen therethrough, the distal end configured for insertion into a luminal organ of a patient, a coupler defining an outlet port and a first port, the coupler configured to engage the proximal end of the first catheter at the outlet port and to receive blood from a blood supply through the first port, a first tube having a proximal end, a distal end, and a lumen therethrough, the distal end of the first tube configured to engage the first port of the coupler and to receive the blood from the blood supply, and a first flow regulator in communication with one or more of the coupler and the first tube, the first flow regulator operable to regulate a flow and/or a pressure of the blood through at least part of the system, wherein the system is configured to permit the blood from the blood supply to flow through the first tube, the coupler, and the first catheter into the patient to treat a patient condition. | 03-12-2015 |
20150088049 | Implantable Mechanical Valve Device for the Treatment of Hydrocephalus Syndrome - An implantable device for the treatment of hydrocephalus syndrome, characterised by a mechanical passive valve device designed to move the cerebrospinal fluid in the cranial site of the patient, comprising a cylindrical body, a piston, and a special spring exhibiting a non-linear characteristic and suitable for applying a force on the piston such that, when the pressure of the cerebrospinal fluid acting on the two opposite faces of the piston exceeds a certain value, a rapid displacement of the piston in the cylindrical body takes place due to the non-linear characteristic of the spring, with consequent aspiration, by the same piston, of a greater quantity of cerebrospinal fluid contained in the ventricle and, when the pressure of the cerebrospinal fluid falls below a certain value, the piston reacts and moves rapidly in a direction opposite to the first, so as to feed into the ventricle the cerebrospinal liquid previously aspirated. | 03-26-2015 |
20150094643 | ADJUSTABLE HEIGHT HYDROCEPHALUS VALVE LOCATION DEVICE - An adjustable height tool for locating a magnetically readable and settable valve implanted in a living being. The locator can include a wall having a first perimeter. A platform can be disposed within the first perimeter. A valve cut-out can disposed within the platform and can approximate at least a portion of the shape of the valve. A movable foot can be disposed below the platform by which a displacement element moves the foot at least one of toward or away from the platform. This movement increases or decreases the distance between the platform and the skin/valve. Two or more recesses can be disposed in the foot and the recesses can be aligned with the valve cut-out. The displacement element can maintain the alignment of the recesses and the cut-out while moving the foot. | 04-02-2015 |
20150094644 | SYSTEMS AND METHODS FOR MOVING AND CIRCULATING FLUID TO TREAT ALZHEIMER'S DISEASE - A system for the treatment of Alzheimer's disease is provided by moving cerebrospinal fluid containing particles know to contribute to onset of Alzheimer's disease from a source of cerebrospinal fluid to the stomach or bladder, where the particles are safely digested by gastric acid or excreted, the system including an implantable pump, an inlet catheter, an outlet catheter, and a one-way valve. The system further includes at least one filter to filter harmful particles from the cerebrospinal fluid and return the filtered cerebrospinal fluid back to the source of cerebrospinal fluid, where the harmful particles blocked by the filter may be rinsed off the filter and transported to the stomach or bladder. | 04-02-2015 |
20150148730 | SHUNT DEVICE AND METHOD FOR TREATING OCULAR DISORDERS - Shunt devices and a method for continuously decompressing elevated intraocular pressure in eyes affected by glaucoma by diverting excess aqueous humor from the anterior chamber of the eye into Schlemm's canal where post-operative patency can be maintained with an indwelling shunt device which surgically connects the canal with the anterior chamber. The shunt devices provide uni- or bi-directional flow of aqueous humor into Schlemm's canal. | 05-28-2015 |
20150148731 | METHODS AND DEVICES FOR INTRA-ATRIAL SHUNTS HAVING ADJUSTABLE SIZES - Devices and methods for treating heart disease by normalizing elevated blood pressure in the left and right atria of a heart of a mammal are disclosed. Devices may include an adjustable hydraulic diameter shunt portion which can be manually adjusted in vivo. Methods are provided for adjusting the flow rate of the devices in vivo. | 05-28-2015 |
20150297874 | SYSTEMS AND METHODS FOR SHUNTING FLUID - Systems and methods are provided herein that generally involve shunting fluid, e.g., shunting cerebrospinal fluid in the treatment of hydrocephalus. Self-cleaning catheters are provided which include split tips configured such that pulsatile flow of fluid in a cavity in which the catheter is inserted can cause the tips to strike one another and thereby clear obstructions. Catheters with built-in flow indicators are also provided. Exemplary flow indicators include projections that extend radially inward from the interior surface of the catheter and which include imageable portions (e.g., portions which are visible under magnetic resonance imaging (MRI)). Movement of the flow indicators caused by fluid flowing through the catheter can be detected using MRI, thereby providing a reliable indication as to whether the catheter is partially or completely blocked. Systems and methods for flushing a shunt system are also disclosed herein, as are various systems and methods for opening auxiliary fluid pathways through a shunt system. | 10-22-2015 |
20150305906 | METHODS AND DEVICES FOR DELIVERING OR DELAYING LIPIDS WITHIN A DUODENUM - Devices and methods described include a flow reduction device adapted and configured for use within the duodenum of a mammal having a spine, a first atraumatic feature, a second atraumatic feature, and a flow reduction element having a proximal end, a distal end, an interior portion, an exterior portion and a variable porosity between the proximal end and the distal end. One aspect of the device includes a spine having a proximal end and a distal end, an atraumatic feature positioned on at least one of the proximal end and the distal end of the spine, and a flow reduction element positioned along the spine and having a variable porosity along its length. | 10-29-2015 |
20150313740 | Gastrointestinal Device - A gastrointestinal device and method for retrieving the device are disclosed. The device may include a stent including a plurality of strands forming first and second ends, the strands configured to move between a retrieval configuration, with substantially parallel strands, and a deployed configuration, wherein the strands form proximal and distal portions having first and second diameters larger than the pyloric sphincter. The device may include a connector assembly including proximal, middle, and distal connectors. The middle connector may be coupled to the proximal and distal connectors when the strands are in the deployed configuration. The strands may be attached to the proximal and distal connectors and the first and second ends. The device may include a release mechanism configured to decouple the proximal connector from the middle connector. Decoupling of the proximal and middle connectors may allow the strands to move from the deployed to retrieval configuration. | 11-05-2015 |
20150313741 | Gastrointestinal Device - A gastrointestinal device for reducing flow through a pyloric sphincter of a patient is disclosed. The device may include a stent including a plurality of strands forming first and second ends, the plurality of strands configured to form a proximal portion having a proximal diameter and a distal portion having a distal diameter. The proximal and distal diameters may be larger than a diameter of the pyloric sphincter and the proximal diameter may be larger than the distal diameter. The device may include a connector assembly including proximal and distal connectors, the plurality of strands being attached to the proximal and distal connectors at the first and second ends. The connector assembly may further include a middle portion extending between the proximal and distal connectors. The middle connector may extend within the plurality of strands, and may be unattached to the plurality of strands. | 11-05-2015 |
20150313742 | Gastrointestinal Device - A gastrointestinal device and method for inserting the device are disclosed. The device may include a stent including a plurality of strands. The stent may move between an insertion configuration, wherein the plurality of strands are substantially parallel, and a deployed configuration, wherein the plurality of strands form a proximal portion having a first diameter and a distal portion having a second diameter. The first and second diameters may be larger than a diameter of the pyloric sphincter. The device may include a connector assembly including proximal and distal connectors attached to the strands. A cable including an engagement portion may be configured to releasably couple to the distal connector and to cause the strands to move from the insertion configuration to the deployed configuration when the engagement portion is coupled to the distal connector and force is applied to the cable in a direction toward the proximal connector. | 11-05-2015 |
20150320596 | Drug Delivery Treatment Device - Disclosed are devices and methods for treatment of eye disease. The suprachoroidal space is used as a conduit within which to place a drug delivery device. One such drug delivery device may be a tube, wicking element, bioabsorbable polymer structure, or other configuration of drug delivery substrate. The delivery device may include a port on the proximal end to assist in repeat injection, and may include a reservoir to either collect flow from the aqueous to concentrate it along the length of the device, or act as a repository for injected agent. | 11-12-2015 |
20150335488 | APPARATUS AND METHODS FOR TREATING EXCESS INTRAOCULAR FLUID - An ocular drainage system is provided for treating diseases that produce elevated intraocular pressures, such as glaucoma, wherein the system includes an implantable device and an external control unit, the implantable device includes a non-invasively adjustable valve featuring at least one deformable tube and a disk rotatably mounted within a housing, such that rotation of the disk using the external control unit causes the disk to apply a selected amount of compression to the deformable tube, thereby adjusting the fluidic resistance of the deformable tube and regulating the intraocular pressure. | 11-26-2015 |
20150343186 | Systems and Methods for Treating Pulmonary Edema - Various systems and methods are provided for treating pulmonary edema. In general, a pump can be configured to be implanted within a patient at risk of developing edema. The pump can be configured to pump fluid out of the patient's lungs, e.g., out of the patient's interstitial and alveolar spaces. The pump can be configured to be fully implanted within the patient's body. The pump can be configured to continuously pump fluid, or the pump can be configured to be selectively actuatable in response to a trigger event. In an exemplary embodiment, the pump can include an inflow port coupled to an inflow tube in fluid communication with a lymphatic vessel of the patient, and can include an outflow port coupled to an outflow tube in fluid communication with a vein of the patient. | 12-03-2015 |
20150352272 | DEVICE FOR PROMOTING FISTULA PATENCY AND METHOD - A device for promoting patency of a fistula includes an annular body and a plurality of vanes formed integrally with the annular body, and projecting inwardly from an inner radial surface thereof. The vanes are oriented so as to impart circumferential velocity components to blood passed through a lumen of the device, and such that an unobstructed line of sight parallel to a central axis of the annular body extends between adjacent ones of the vanes. | 12-10-2015 |
20150366692 | APPARATUS AND METHOD FOR DRAINING MATERIAL FROM A STOMACH - This invention relates to new apparatuses for draining material from a stomach and infusing fluid into the stomach comprising a tubing connector, a housing unit, and a one-way valve. In an embodiment the connector can have a first port, a second port, a third port and a branched lumen that extends through each of the first, second and third ports. The housing unit can have a housing lumen that is sized and shaped to receive the third port and the housing unit is sized and shaped to receive the connector. The one-way valve can be sized and shaped to be received in the housing lumen. | 12-24-2015 |
20150366716 | SYSTEM AND METHOD FOR TREATMENT OF NON-VENTILATING MIDDLE EAR BY PROVIDING A GAS PATHWAY THROUGH THE NASOPHARYNX - Methods and devices for providing a gas pathway between the nasopharynx and the Eustachian tube are provided. One device may include a lumen with a valve. A portion of the valve may be tethered to adjacent muscle. Another portion of the valve may be tethered to adjacent cartilage. When the muscle contracts the valve may open through movement of the tethers, and provide a gas pathway between the nasopharynx and the Eustachian tube. | 12-24-2015 |
20150367110 | SYSTEMS AND METHODS FOR SHUNTING FLUID - Systems and methods are provided herein that generally involve shunting fluid, e.g., shunting cerebrospinal fluid in the treatment of hydrocephalus. Self-cleaning catheters are provided which include split tips configured such that pulsatile flow of fluid in a cavity in which the catheter is inserted can cause the tips to strike one another and thereby clear obstructions. Catheters with built-in flow indicators are also provided. Exemplary flow indicators include projections that extend radially inward from the interior surface of the catheter and which include imageable portions (e.g., portions which are visible under magnetic resonance imaging (MRI)). Movement of the flow indicators caused by fluid flowing through the catheter can be detected using MRI, thereby providing a reliable indication as to whether the catheter is partially or completely blocked. Systems and methods for flushing a shunt system are also disclosed herein, as are various systems and methods for opening auxiliary fluid pathways through a shunt system. | 12-24-2015 |
20150367111 | Ostomy Pump System and Related Methods of Use and Manufacture - A device for refeeding bowel content of a subject configured to cover a proximal ostomy of a subject and a distal member configured to cover a distal ostomy of a subject. The device may include a bowel lumen member configured to carry bowel contents between the proximal ostomy and the distal ostomy. A method for refeeding bowel content of a subject by disposing a bowel lumen member between a proximal ostomy and distal ostomy, wherein the bowel member is configured to carry bowel contents between the proximal ostomy and the distal ostomy. | 12-24-2015 |
20150374546 | ENHANCEMENT OF AQUEOUS FLOW - Drainage of body fluid from an area of undesirably high pressure can be accomplished by interconnecting an artificial non-blood fluid conduit with the vascular system. For example, an artificial non-blood fluid conduit can be inserted into the eye to fluidly interconnect the anterior chamber with a location of lower pressure. The conduit can have a growth factor for stimulating growth of new blood vessels in the location of lower pressure to connect the new blood vessels with the non-blood fluid conduit. | 12-31-2015 |
20150374961 | SYSTEM AND METHOD FOR DETERMINING POSITION AND PRESSURE OF AN IMPLANTABLE SHUNT - In one aspect, an implantable shunt system is disclosed that, in one example implementation, includes a resilient member and a connected fluid regulating device. The fluid regulating device selectively permits fluid flow through an opening valve of an implantable shunt according to an adjustable opening pressure. The opening pressure is proportional to an amount of tension on the resilient member. One or more tension sensors that are connected to the resilient member measure an amount of tension on the resilient member. The tension sensors generate tension data that corresponds to the measured amount of tension. The system further includes a communication unit with a transmitting unit that transmits the measured data over a communication link. The system also includes a reading unit that receives the transmitted tension data over the communication link. The reading unit includes a connector that electrically connects the reading unit to the transmission unit. | 12-31-2015 |
20160000568 | DEVICES AND METHODS FOR CONTROLLING BLOOD PERFUSION PRESSURE - Devices and methods for controlling blood perfusion pressure. In an exemplary device for controlling blood perfusion pressure within a vessel of the present disclosure, the device comprises an elongated body having a lumen, a proximal end configured for placement in a first area having a first blood pressure, and a distal end configured for placement in a second area having a second blood pressure, partial occluder positioned within the lumen of the elongated body between the proximal end and the distal end, the partial occluder configured so not to fully occlude a blood vessel, wherein the partial occluder is configured to equalize the first blood pressure at the first area with the second blood pressure at the second area. | 01-07-2016 |
20160015564 | DRUG-DELIVERY PUMPS AND METHODS OF MANUFACTURE - Embodiments of method of manufacturing an implantable pump, including providing an upper layer comprising a dome structure for housing a drug chamber and a cannula in fluid communication with the drug chamber, providing a middle deflection layer adjacent the drug chamber, providing a bottom layer comprising electrolysis electrodes, and bonding the upper layer, middle deflection layer, and bottom layer to form the pump. | 01-21-2016 |
20160022423 | METHODS, SYSTEMS, AND DEVICES FOR RESIZABLE INTRA-ATRIAL SHUNTS - Devices and methods for treating heart disease by normalizing elevated blood pressure in the left and right atria of a heart of a mammal are disclosed. Devices may include an adjustable hydraulic diameter and/or a removable and/or replaceable shunt portion. Devices may include absorbable materials, the absorption of which directly or indirectly causes alterations of the fluid flow capacities the devices. | 01-28-2016 |
20160022971 | APPARATUS AND METHODS FOR TREATING INTRACORPOREAL FLUID ACCUMULATION - A fluid management system for the treatment of ascites, pleural effusion or pericardial effusion is provided including an implantable device including a pump, control circuitry, battery and transceiver; a charging and communication system configured to periodically charge the battery and communicate with the implantable device to retrieve performance data; and monitoring and control software, suitable for use with conventional personal computers, for configuring and controlling operation of the implantable device and charging and communication system. The implantable device includes a number of features that provide automated movement of fluid to the bladder with reduced risk of clogging, with no patient involvement other than occasional recharging of the battery of the implantable device. The monitoring and control software is available only to the treating physician, such that the physician interacts with the implantable device via the charging and communication system. | 01-28-2016 |
20160030647 | SYSTEM AND METHOD TO INCREASE THE OVERALL DIAMETER OF VEINS - A system and method for increasing the speed of blood and wall shear stress (WSS) in a peripheral vein for a sufficient period of time to result in a persistent increase in the overall diameter and lumen diameter of the vein is provided. The method includes pumping blood at a desired rate and pulsatility. The pumping is monitored and adjusted, as necessary, to maintain the desired blood speed, WSS and pulsatility in the peripheral vein in order to optimize the rate and extent of dilation of the peripheral vein. | 02-04-2016 |
20160030648 | SYSTEM AND METHOD TO INCREASE THE OVERALL DIAMETER OF VEINS - A system and method for increasing the speed of blood and wall shear stress (WSS) in a peripheral vein for a sufficient period of time to result in a persistent increase in the overall diameter and lumen diameter of the vein is provided. The method includes pumping blood at a desired rate and pulsatility. The pumping is monitored and adjusted, as necessary, to maintain the desired blood speed, WSS and pulsatility in the peripheral vein in order to optimize the rate and extent of dilation of the peripheral vein. | 02-04-2016 |
20160038724 | SHUNT FLUSHER - A device and system for flushing a shunt catheter utilizes the available cerebrospinal fluid (CSF) to flush a blocked catheter. The CSF is pressurized to a predetermined amount and then allowed to suddenly, rapidly and forcefully purge any occlusions. The rapid release of CSF produces flow jets from the catheter pores into the ventricle. This impulse, or “cough”, will push and divert choroid plexus and/or other blockages away from the pores. The device and system may then be allowed to refill at a slow rate, thus reducing the possibility of rapid suction of fluid back into the system and the attendant possibility of drawing the choroid plexus back into the pores. The catheter at the proximal end may also include back-up pores that can be opened to restart flow from the ventricle should the primary pores remain blocked after a flushing attempt. | 02-11-2016 |
20160058615 | DEVICE AND METHOD FOR REDUCING INTRAOCULAR PRESSURE - An apparatus is provided for draining aqueous humor from an eye for reducing intraocular pressure. The draining apparatus comprises a tube defining a passage for fluid flow between an inlet end and an outlet end. An outlet assembly contacts the conjunctival layer externally of the eyeball. The outlet assembly comprises a housing in fluid communication with the outlet end of the tube and having an aperture for allowing egress of aqueous humor onto the external ocular surface. A resistive component is disposed in the housing for providing resistance to a flow of aqueous humor. A pair of tabs project outwardly and are adapted to be disposed subconjunctivally for securing the draining apparatus relative to the eyeball. | 03-03-2016 |
20160058616 | APPARATUS AND METHOD FOR REDUCING INTRAOCULAR PRESSURE - An apparatus for reducing/stabilizing intraocular pressure is provided. A tube extends from an inlet end in fluid communication with an anterior chamber of the eye, to direct an aqueous humor flow from the anterior chamber to an outlet end in fluid communication with a cavity, defined by a housing, for receiving the aqueous humor. A flow control device is operably engaged with the housing, and is configured to control the flow of the aqueous humor, via a conduit defined thereby and extending from the cavity, to a location away from the anterior chamber. The conduit is dilatable in response to the intraocular pressure being above a preselected pressure, to increase the flow or to decrease resistance to flow of the aqueous humor through the conduit to the drainage site and to reduce the intraocular pressure to no greater than the preselected pressure. Associated apparatuses and methods are also provided. | 03-03-2016 |
20160067084 | Optic Nerve Implants - Methods and devices for delivering therapeutic substances into the eye. An implant containing the therapeutic substance is implanted at least partially within the optic nerve and the therapeutic substance then elutes from the implant. The implant may have a lumen or it may be solid. | 03-10-2016 |
20160067093 | DEVICES, SYSTEMS AND METHODS FOR POSTERIOR SEGMENT DRAINAGE - Described herein is a method of implanting a glaucoma drainage device in an eye having a vitreous chamber and a drainage site. The glaucoma drainage device comprises a tube including a lumen extending from an inlet end to an outlet end, and includes a control element that regulates the amount of fluid flow through the glaucoma drainage device. The method comprises implanting the glaucoma drainage device into pars plana tissue from the vitreous chamber, such that the device extends between the vitreous chamber and the drainage site. | 03-10-2016 |
20160067463 | Methods and Devices for Locating and Adjusting an Implantable Valve - Methods and devices are provided that allow a physician to consistently and reliably locate an implantable, magnetically settable valve (valve) and to determine and/or change (adjust) a setting of the valve from a current setting to a target setting without interference from the valve and/or patient's skin. In particular, various locator tools are provided that include a housing having a deck extending thereacross that is formed at least in part of a material which is moveable to accommodate a protrusion of a hydrocephalus valve beneath skin. | 03-10-2016 |
20160067464 | METHOD AND SENSOR FOR DETECTING CATHETER OBSTRUCTION - A self-monitoring catheter system may detect an obstruction during use of a catheter. The system may include a catheter with an interior lumen that has one or more ports into the lumen; a first and a second electrode; and an impedance measurement instrument that measures changes in the impedance between the first and the second electrodes after the first electrode is exposed to fluid within the catheter lumen, thereby signaling an obstruction during use of the catheter. | 03-10-2016 |
20160074638 | VENTRICULOPERITONEAL SHUNT WITH PRESSURE RESPONSIVE ELEMENT - A ventriculoperitoneal shunt includes a proximal catheter, a distal catheter, a shunt valve operably coupling the proximal catheter to the distal catheter, and a contrast container containing contrast material configured to change acoustic impedance proportionally to a change in pressure applied to the contrast container. | 03-17-2016 |
20160082231 | ENDOVASCULAR CEREBROSPINAL FLUID SHUNT - An endovascular implantable shunt device for draining cerebrospinal fluid from a patient's subarachnoid space includes a shunt having opposed first and second ends, a one-way valve located at the first end of the shunt, a helical tip disposed at the second end, and a hollow passageway extending between the helical tip and one-way valve. The helical tip is constructed to penetrate a patient's sinus wall. Cerebrospinal fluid drains through the helical tip and out through the valve. | 03-24-2016 |
20160089255 | REMOVABLE VASCULAR OCCLUSION DEVICE - Disclosed herein are embodiments of an occlusion device that can be delivered into the vascular system of a patient for inducing weight loss. The device can be formed from a body that can expand from a collapsed to an expanded position, where the body can be configured to at least partially occlude a blood vessel. Further, the device can comprise a first and second end joined by a center section. One of the ends can contain a retrieval element for easily removing the device from the patient. | 03-31-2016 |
20160089256 | DELIVERY DEVICES AND METHODS FOR GASTROINTESTINAL IMPLANTS - Several gastrointestinal surgery procedures are effective as treatments for metabolic disorders such as obesity and diabetes. Minimally invasive procedures including intra-luminal gastrointestinal implants have been proposed to mimic the anatomical, physiological and metabolic changes achieved by these procedures. Many of these designs include long sleeve like elements that prevent contact of food with the walls of the small intestine. It is desirable to have simple delivery systems that can place these implants under endoscopic guidance. However, in order to anchor these sleeve elements safely and reliably, the inventors have previously disclosed anchoring means that anchor the sleeves at the junctions of the stomach and the intestine or the stomach and esophagus. | 03-31-2016 |
20160089519 | OPTOELECTRONIC SENSING OF A SUBCUTANEOUS IMPLANT SETTING - Systems and methods are provided for optically reading a setting of an implantable valve. The valve includes optical emitters that are wirelessly powered by a valve reading tool that images the emitted light to determine the valve setting. | 03-31-2016 |
20160089521 | IMPLANTABLE SHUNT OR CATHETER ENABLING GRADUAL DELIVERY OF THERAPEUTIC AGENTS - An implantable catheter or shunt for draining fluid from a body cavity. The catheter or shunt body has a wall structure that carries one or more therapeutic agents in a manner enabling release of the therapeutic agent from the wall structure in situ after surgical implantation of the catheter or shunt body. The therapeutic agent can be gradually released over time to prevent infection, inhibit tissue ingrowths, and/or provide some other desired medicinal purpose. As an example, the therapeutic agent can be rapamycin or an mTOR inhibitor. According to some contemplated embodiments of the present invention, the therapeutic agent carried by the catheter/shunt is rechargeable or refillable in situ so that the therapeutic agent can be gradually released from the catheter/shunt over the expected useful life of the catheter/shunt. | 03-31-2016 |
20160095731 | Colonnade (TM) Expandable Intragastric Food Flow Lumen Device - This invention is an expandable intragastric device for reducing food consumption and/or absorption. In an example, this device can be embodied in a plurality of longitudinal expandable members which are arranged in a colonnade configuration to form a restrictive food lumen within a stomach. Pumping a flowable substance between the interiors of these expandable members changes the rate of food flow through the stomach, the capacity of the stomach to hold food, and/or the amount of food absorbed by the body. This offers some of the beneficial effects of gastric sleeve surgery, while also being adjustable and reversible. | 04-07-2016 |
20160101270 | DRAINAGE SYSTEMS FOR EXCESS BODY FLUIDS AND ASSOCIATED METHODS - Drainage systems for excess body fluids and associated methods are disclosed herein. A body fluid drainage system in accordance with an embodiment of the present technology, for example, can include a catheter that has an exterior surface, a proximal portion, and a distal portion opposite the proximal portion. The body fluid drainage system can further include a valve device, a pressure sensor, and a controller operatively coupled to the valve device and the pressure sensor. The valve device can include an actuator positioned over the exterior surface of the catheter. The actuator is movable between an open position that allows body fluid flow through the catheter, a closed position that at least substantially obstructs the body fluid flow through the catheter, and intermediate positions that partially obstruct the body fluid flow through the catheter. The controller can change the position of the actuator in response to a predetermined condition of the pressure sensor. | 04-14-2016 |
20160106962 | ADJUSTABLE HEIGHT HYDROCEPHALUS VALVE LOCATION DEVICE - An adjustable height tool for locating a magnetically readable and settable valve which includes a wall having a first perimeter. A platform can be disposed within the first perimeter. A valve cut-out can disposed within the platform and receive at least a portion of the valve. A movable foot can be disposed below the platform by which a displacement element moves the foot at least one of toward or away from the platform, in fixed increments of about 1.5 mm, upon rotation of the displacement element. This movement increases or decreases the distance between the platform and the skin/valve. | 04-21-2016 |
20160113799 | SATIATION DEVICES AND METHODS - A device for inducing weight loss in a patient includes a tubular prosthesis self-expandable from a collapsed position in which the prosthesis has a first diameter to an expanded position in which the prosthesis has a second, larger, diameter. In a method for inducing weight loss, the prosthesis is placed in the collapsed position and inserted into a stomach of a patient. The prosthesis is allowed to self-expand from the collapsed position to the expanded position and into contact with the walls of the stomach, where it induces feelings of satiety and/or inhibits modulation of satiety-controlling factors such as Ghrelin. | 04-28-2016 |
20160136398 | METHODS AND SYSTEMS FOR TREATING HYDROCEPHALUS - Methods for treating hydrocephalus using a shunt, the shunt having one or more CSF intake openings in a distal portion, a valve disposed in a proximal portion of the shunt, and a lumen extending between the one or more CSF intake openings and the valve, the method comprises deploying the shunt in a body of a patient so that the distal portion of the shunt is at least partially disposed within a CP angle cistern, a body of the shunt is at least partially disposed within an IPS of the patient, and the proximal portion of the shunt is at least partially disposed within or proximate to a JV of the patient, wherein, after deployment of the shunt, CSF flows from the CP angle cistern to the JV via the shunt lumen at a flow rate in a range of 5 ml per hour to 15 ml per hour. | 05-19-2016 |
20160143781 | VALVE DEVICE FOR USE IN GLAUCOMA SURGERY - A valve device for use in glaucoma surgery comprises at least one aqueous humor feeding duct ( | 05-26-2016 |
20160158432 | DIALYSIS VALVE AND METHOD - A dialysis valve includes a tube attached between an artery and a vein which, when elongated, simultaneously narrows in diameter at at least one location. The narrowed portion of the tube decreases the volume and velocity between the arterial and venous side of the patient to prevent damage or intimal hyperplasia on the venous side between dialysis treatments. When the valve is opened for dialysis, an unrestricted blood flow exists between the arterial and venous side, permitting a controlled, open blood flow during dialysis. | 06-09-2016 |
20160166754 | UNITARY BODY SYSTEMS AND DEVICES AND METHODS TO USE THE SAME FOR RETROPERFUSION | 06-16-2016 |
20160166813 | FLUID FLOW CONTROL DEVICES, ROTORS AND MAGNETS WITH INCREASED RESISTANCE TO INADVERTENT SETTING CHANGE AND IMPROVED ACCESSORY TOOL COUPLING | 06-16-2016 |
20160184124 | METHOD FOR PERFORMING A GASTRECTOMY - A method for performing a gastrectomy (stomach reduction surgery). | 06-30-2016 |
20160184561 | METHODS AND DEVICES FOR INTRA-ATRIAL SHUNTS HAVING SELECTABLE FLOW RATES - Devices and methods for treating heart disease by normalizing elevated blood pressure in the left and right atria of a heart of a mammal are disclosed. The devices are adapted to permit fluid flow across the membrane in which the device is implanted at first rate, and at a second rate, wherein a difference between the first rate and the second rate is not solely dependent upon variations in blood pressure differential across the membrane due to the heart's pumping cycle. | 06-30-2016 |
20160184562 | DETECTION AND CLEARING OF OCCLUSIONS IN CATHETERS - A catheter system with integral sensing and clearing of occlusions is described. The system can include a catheter in fluid communication with a shunt for transporting a bodily fluid within, or out of, a patient's body. The catheter and/or the shunt can include one or more detection wires and one or more transmission wires. The detection wires can be in electrical communication with the fluid and can enable the detection of changes in electrical properties of the fluid indicating an occlusion, or other anomaly, in the catheter. The transmission wires can be in electrical communication with the fluid and can enable the application of electromagnetic energy to the occlusion to facilitate its removal. The detection wires and the transmission wires can be the same or different wires. The system can include a probe that can be externally connected to the wires to provide detection and or transmission signals. | 06-30-2016 |
20160184563 | ADJUSTMENT FOR HYDROCEPHALUS SHUNT VALVE - An implantable medical device is disclosed that includes a valve seat and a valve member movable with respect to the valve seat. An adjustment circuit assembly includes a resistive element that is coupled to the valve member and operable to position the valve member relative to the valve seat so as to alter the pressure setting in response to a current applied to the resistive element. | 06-30-2016 |
20170232240 | SHUNT FLOW MONITOR | 08-17-2017 |
20170232241 | METHOD OF TREATING COPD WITH ARTIFICIAL ARTERIO-VENOUS FISTULA AND FLOW MEDIATING SYSTEMS | 08-17-2017 |
20190142570 | Bronchoscopic Lung Volume Reduction Valve | 05-16-2019 |